Relatório de estágio: gestão editorial na ARC Publishing by Araújo, José Luís Lopes de
  
 
 
Universidade de Aveiro  
2013 
Secção Autónoma 
de Ciências da Saúde 
JOSÉ LUÍS  
LOPES DE  
ARAÚJO 
 
RELATÓRIO DE ESTÁGIO:  
GESTÃO EDITORIAL NA ARC PUBLISHING. 
 
 
INTERNSHIP REPORT:  
EDITORIAL MANAGEMENT AT ARC PUBLISHING. 
 
 
  
  
 
 
Universidade de Aveiro  
2013 
Secção Autónoma 
de Ciências da Saúde 
JOSÉ LUÍS  
LOPES DE  
ARAÚJO 
 
RELATÓRIO DE ESTÁGIO:  
GESTÃO EDITORIAL NA ARC PUBLISHING. 
 
 
INTERNSHIP REPORT:  
EDITORIAL MANAGEMENT AT ARC PUBLISHING. 
 
 
 Relatório apresentado à Universidade de Aveiro para cumprimento dos 
requisitos necessários à obtenção do grau de Mestre em Biomedicina 
Farmacêutica, realizado sob a orientação científica do Professor Doutor 
José Luís de Almeida, Sócio Gerente da ARC Publishing e Professor 
Associado Convidado da Secção Autónoma de Ciências da Saúde da 
Universidade de Aveiro; e da Professora Doutora Alexandra Isabel 
Cardador de Queirós, Professora Coordenadora da Escola Superior de 
Saúde da Universidade de Aveiro. 
 
  
  
 
o júri   
 
presidente Professor Doutor Nelson Fernando Pacheco da Rocha 
Professor Catedrático da Secção Autónoma de Ciências da Saúde  
da Universidade de Aveiro 
  
 
 Professor Doutor José Luís de Almeida 
Professor Associado Convidado da Secção Autónoma de Ciências da Saúde  
da Universidade de Aveiro 
  
 
 Professora Doutora Alexandra Isabel Cardador de Queirós 
Professora Coordenadora da Escola Superior de Saúde da Universidade de Aveiro 
  
 
 Professora Doutora Maria Joana da Costa Gomes da Silva 
Professora Adjunta da Escola Superior de Saúde da Universidade de Aveiro 
  
  
 
 
 
 
 
 
 
 
 
 
palavras-chave 
 
Redação e Comunicação Científica; Estatística; Editor; Revisão por pares; 
Acesso livre; Gestão Editorial; 
resumo 
 
 
Os principais objetivos do meu estágio em gestão editorial, na ARC 
Publishing, estavam ligados com o desenvolvimento do International 
Journal of Clinical Neurosciences and Mental Health e com tarefas de 
redação e comunicação científica. Após um período inicial, fui convidado a 
participar mais ativamente nas tarefas de gestão da empresa, promovendo 
o seu crescimento. Ambos os objetivos foram atingidos. Fui, juntamente 
com a equipa na qual fui integrado, capaz de criar uma sólida estrutura de 
suporte para a revista científica, incluindo um vasto painel de editores e 
uma plataforma para submissão de artigos e gestão do processo de 
revisão por pares. Como comunicador científico, participei na elaboração 
de 2 artigos, revi e executei métodos estatísticos, editei capítulos de livros, 
preparei cadernos de recolha de dados, e escrevi instruções para autores 
e textos comerciais (entre outros trabalhos). Estive também envolvido no 
registo da marca ARC Publishing, na sua promoção e na arquitetura de 
uma estrutura de qualidade que a fará uma referência futura nas agências 
de comunicação dedicadas ao conteúdo médico. 
Durante o estágio, melhorei as minhas apetências técnicas em redação, 
edição e comunicação científica. No entanto, os maiores ganhos foram ao 
nível do desenvolvimento de apetências de gestão e de relacionamento 
interpessoal. Globalmente, atingi os objetivos traçados para o período de 9 
meses de estágio, cresci como profissional e contribuí para o 
desenvolvimento da ARC Publishing. 
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The main goals of my internship as associate editorial manager in ARC 
Publishing were to develop the International Journal of Clinical 
Neurosciences and Mental Health and to perform medical writing tasks. 
Bound with those objectives, and as result of the empowerment in the first 
months, I was invited to actively manage ARC Publishing activities and to 
promote the company growth. Both goals were achieved. We, me and my 
teammates, were able to build a solid editorial board for the journal and an 
information technology infrastructure to support the journal publication, 
manuscript submission and peer-review process. As medical writer, I 
participated in the writing of 2 original manuscripts, revised and executed 
statistical methods, edited book chapters, prepared case report forms, and 
wrote instructions for authors and marketing texts (among several other 
works). We also registered ARC Publishing brand, promoted it among our 
clients and built internal resources (by staff training and quality procedures) 
to guarantee ARC’s future as a reference brand in medical writing for 
private clinicians.  
During my internship I improved my medical writing and editorial skills. But 
my greater gains were in interpersonal and management skills. Globally, I 
met the objectives set for the 9 months period, growing as professional and 
contributing to ARC Publishing development. 
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1 Introduction 
The curricular training at ARC publishing was presented to me as a diverse and 
challenging development of a start-up company. In the following sections I describe the 
objectives of the internship. To contextualize I included also an overview of the publishing 
and medical writing landscape. Section 2 presents the methods available (i.e. how the 
company enabled my work). In Section 3 I describe my activities and results, which are 
discussed in section 4. A conclusion is presented in the last section. 
During this report you may notice a massive use of the word “We”. The use of “We” is due 
to the preference for active voice, but also because all my work was not possible without 
the collaboration of Professor Luis Almeida (supervisor and ARC’s Managing Partner) and 
Tiago Campos (colleague and medical writer trainee). 
1.1 Objectives 
The job title “Associate Editorial Manager” is as broad as the spectrum of the objectives 
during the training. The major objectives can be related to 2 main areas: publishing 
activity and medical writing activity. On top of those, we added the objective of developing 
the ARC’s business by engaging clients and finding marketing solutions. 
Publishing activity was at the core of my internship. In the first 3 months (one third of total 
internship duration) the objective was to develop the International Journal of Clinical 
Neurosciences and Mental Health (IJCNMH). This task includes: interaction with Editor-in-
Chief and Associate Editors to understand their needs; selection and invitation of the 
members of the editorial board; development of contact database for dissemination and 
marketing activities; planning (and production management) of journal website and peer-
review platform; writing of guidelines for authors and reviewers; and writing of website 
contents. To better accomplish those tasks, the initial period of the internship was spent at 
the Psychiatry Department of S. João Hospital (Porto, Portugal)—the workplace of the 
Editor-in-Chief. The secondary objective in publishing activities was the edition of books 
and book chapters. 
Our aim in the medical writing activities was to produce: scientific articles for submission 
to peer-review journals; oral presentation materials; Standard Operating Procedures 
(SOPs), internal and for other companies; translations of regulatory documents; and Case 
Report Forms (CRFs). To support medical writing activities, we also planned to write 
SOPs for statistical analysis and data management. 
Management interconnects the objectives in publishing and writing. We aimed to develop 
a quality system—based on parallel processing and virtual team workflow—and to 
develop ARC’s brand and business. In this category, objectives included the development 
of: SOPs, marketing materials, websites, and client interactions. At last, but definitely not 
at least, one important objective was to supervise an internship of an Associate Medical 
Writer. 
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1.2 Publishing landscape 
1.2.1 Scientific journals and review process 
The first scientific journal was published in January of 1665—the Journal Des Savants—
by the hands of the Académie des Sciences in Paris. It was a close call, 2 months later 
the Royal Society (London) published the Philosophical Transactions (1). But the Royal 
Society was the one to establish the principles of scientific priority and accuracy by 
editorial and peer-review. In fact peer-review was created to legitimate the editor’s choice 
(1-3). The peer-review and basic principles of scientific editorial revision remained for 300 
years, but are now thriving to change. In this section I will review how we stand regarding 
to academic publishing, the boom of the open-access and the issues arising from peer-
review and overall cost of transmitting knowledge. 
In early years scientists communicated their findings using letters with the objective of 
learning from peers. Scientific publishing (along with peer-review) replaced the inefficient 
letter system, adding degrees of freedom to the process, i.e. more scientists could 
intervene (4). The peer-review was increasingly standardized after 1950’ science boom, 
with the creation of editorial and review boards. The main process is represented in Figure 
1. The differences between peer-review processes are in the decision to disclose 
identities of the authors or the reviewers: in single-blind mode the reviewers know the 
author identity and the author is blinded to reviewers; in double-blind mode neither the 
reviewers nor the author know the identities; in open review all the identities are disclosed.  
 
Figure 1. Schematic representation of the peer-review process. Immediate article rejection (e.g. out 
of journal scope) is represented by the dashed line. 
The nowadays peer-review and publishing system is incontestably the only legitimate way 
of disseminating scientific information. It influences all aspects of research. Scientists 
even perceive publications (and their impact factor) as a currency: of utmost importance 
for reaching investigation funds. But peer-review as we know it will likely not endure, it 
needs to adapt to an internet driven system (5). In medical sciences the rate of new 
information is tremendous (5). The title of the paper from Bastian and colleagues states 
the scientific/medical problem: “Seventy-Five Trials and Eleven Systematic Reviews a 
Day: How Will We Ever Keep Up?”(6).  
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If press and paper scientific journals shaped peer-review and enriched the process, online 
publishing is certainly pushing the boundaries of scientific communication. Authors are no 
longer dependent on publishers to disseminate information. In fact they can disseminate it 
faster in other formats that may impact a specific scientific audience (4). Change is 
occurring inside and outside journals. In journals we can observe a clear trend towards 
open-access publications (5). Open-access is an online driven change that aims to deal 
with a greater scientific output by lowering the costs for the authors. It also makes the 
article more accessible for the community, which is a response to the crescent need to 
disseminate the information the faster way possible. But although it is a visible trend 
(Figure 2) it does not solve the issue with long and erratic peer-review cycles. It does not 
also solve (in fact it contributes to) the problem that more articles mean that more 
reviewers are needed; the number of experts available is not meeting peer-review 
demand (5). 
 
Figure 2. Open-access publication trends from 1993 to 2009. Adapted from (5). 
Journals are trying to improve the efficiency of peer-review cycles. Large groups as 
BioMed Central (BMC) are already re-using the reviewers’ feedback inside the group 
journals. One of BMC managers, Matthew Cockerill, referred that Genome Biology only 
accepts 10% of the papers submitted, but passes 40% of the rejected manuscripts to 
other BMC journals; from those papers about 50% end up published (7). A large scale of 
this passing philosophy is being implemented by Rubriqs, which is a company that aims to 
promote professional peer-reviewing. In this model the author pays for a fast and 
independent review that will be available for the journals which are recruiting the service 
(the expected fees for authors are between 500$-700$). A small but powerful group of 
publishers already adhered to this initiative, including: Public Library of Science, Karger 
Publishers, F1000Research and John Wiley & Sons; Rubriqs holds (April 2013) a group of 
500 professional reviewers (7). 
But there is also a movement to publish in less conventional formats, or even to not 
publish at all as a protest for the journals costs. Academics more and more practice open-
science, sharing their data in repositories as figshare, GenBank, Dryad, GitHub among 
others; and even sharing their methods by open-notebook philosophy. New approaches 
0
1000
2000
3000
4000
5000
0
40000
80000
120000
160000
200000
1993 1995 1997 1999 2001 2003 2005 2007 2009
n
º 
o
f 
o
p
e
n
-a
c
c
e
s
s
 
J
o
u
rn
a
ls
n
º 
o
f 
o
p
e
n
-a
c
c
e
s
s
 
A
rt
ic
le
s
year
Articles Journals
 18  
 
also include blog posts, comments, and social media integration.  One of the blog/pre-
publication approaches—popular in mathematics and physics—is ArXiv.org from Cornell 
University Library. It is likely that in the near future the majority of the academics will join 
those open networks driven by the fear of being excluded from important decisions or 
projects (4, 8, 9).   
In an interesting Nature paper, Priem defends that the shift to online publications will have 
3 main consequences: 1) the increase in information flow will swamp the filters (as peer-
review) designed for paper-based systems, and the manual controlling methods will fail to 
deal with the new paradigm; 2) the use of new metrics to evaluate scholarship success, as 
views, approvals or mentions in discussions, will replace the citation system; 3) as 
consequence of 1) and 2), reviewers and editors will be replaced by the community 
judgement, the information burden will therefore be a solution to its problem (imitating 
what happened with Google’s ranking algorithm for filtering web-searches) (4). 
To the reader still unwilling to accept the change in scientific publishing, lets also have a 
look at more radical movements. A group of prominent researchers (leaders in their field, 
mostly in mathematical and fundamental research) is refusing to publish or participate in 
review process. This movement is called the “cost of knowledge” and basis its boycott in 
the fact that authors type and pre-format their papers and the online distribution costs are 
low: which lowers the overall publishing costs. Despite of this, the price of university 
journal subscriptions continues to raise, with the State (the majority of fundamental 
research uses public resources) financing the research, the writing, the publishing fees 
and still having to pay to access the publication (10).  In a nutshell we—as taxpayers, 
authors and reviewers (by voluntary work)—are paying for a service that can easily be 
replaced. 
1.2.2 Issues in peer-review and open-access 
Clinical study related publications hold a different scenario. Regulatory authorities demand 
public divulgation (preferably by publication in peer-review journals) of clinical research 
results. Industry is also interested in publication of results, which may be read by key 
opinion leaders and impact drug sales. To better understand the issue in trial reporting, 
we have to consider an additional fact: publication is biased to positive results (11). 
So we have editors that are looking for positive results and industry that is happy to hide 
negative results. That is truly an unfortunate combination, which may be dangerous and 
do not help doctors to select the best possible treatment for their patients. The specific 
biases in clinical research have been reported by several authors (11, 12).  Lee at al. 
analysed the publications from 90 Food and Drug Administration’s approved drugs, 
reporting that: more than half (67%; N= 909) of the trials were not published 5 years after 
drug approval; and original articles were more likely to be published for trials with large 
populations (pivotal) and when statistical significant results were present (11).  
Furthermore, Ramsey and Scoggins analysed oncology trials (N=2028) publications: only 
18% of the trials were found in PubMed; within pharmaceutical industry the proportion of 
published trials is even lower—about 6%, contrasting with 60% from clinical trial networks; 
the results were positive in approximately 65% of the studies (12). 
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1.2.3 Medical journal structure and ICJME guidance 
The International Committee of Medical Journal Editors (ICMJE) guideline (Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals) is an essential 
document to every journal in clinical research. It includes ethical considerations in the 
conduct and report of scientific research, standards for manuscript preparation, 
submission and publishing, and editorial issues. The guideline is focused on very 
important issues as authorship, acknowledgements, editorship, peer-review, the conflicts 
of interest, privacy, and confidentiality. It presents also ethical standards for protection of 
humans and animals in research (13). 
To standardize the report of original research, the ICJME presents their views on how a 
manuscript should be structured and the contents of each section. It also provides 
guidance on reference style and format. The submission, review and editorial process are 
also detailed (13). The guidance contents are transposed to a vast number of journals—
1305 journals are listed in the ICJME website (14), including all the heavy-weights as The 
Journal of the American Medical Association, The Lancet, British Medical Journal, etc.—
who implemented them in their editorial policies and instructions for authors. 
1.3 Medical writing landscape 
1.3.1 Spectrum 
Medical writing is a challenging and demanding activity. It needs a broad spectrum of 
skills to cover a large number of documents. In this sub-section I review the major areas 
and tasks of medical writers and other associated careers. I also included some of the 
major criticism regarding authorship of professional writers. 
The job title speaks for the function: the writing of medical content. The challenge in 
describing medical writing is not about the function (to write) but more about the diversity 
of documents. Documents and its finalities will dictate the medical writer type of activity. 
The European Medical Writers Association (EMWA) divides—in some opinion papers (15) 
and also at the main website (16)—medical writing in regulatory writing, scientific 
communications, marketing/journalism and translations. Regulatory writing includes the 
preparation of study documents for drug approval (clinical study protocols, clinical study 
reports, investigator brochure, etc.), the summary of medicinal product characteristics and 
patient leaflet, support for marketing products and the value dossiers 
(pharmacoeconomics studies, including systematic reviews). Scientific communications 
refer to the writing of manuscripts for peer-review journals, conference posters and 
abstracts, book chapters, oral communication materials (for clinicians or for medical 
scientific liaisons) and scientific online text. Documents respecting marketing and 
journalism categories are usually derived from the above mentioned and may include: 
marketing online text, sales representative materials (and training), newsletters, articles of 
medical journalism and public relations activities. Finally, medical writers may be involved 
in translations, because the wording may need not only clinical adaption but also to be 
tailored for effective communication with regional authorities. 
Medical writers may work in all the mentioned areas (rare cases, typically freelancers) but 
often are specialized in 1 or 2 areas (15). The specialization is not due to lack of capacity, 
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it is frequently related with the focus of the employer. Some authors may even suggest 
medical writing in a spectrum of activities, with the regulatory in the front-end and 
marketing/translations at the back-end (15). 
1.3.2 Functions, skills and metrics 
The medical writing functions, skills and metrics are strongly related to the job and the 
employee affiliation. Medical writers (although not always with this designation) can be 
found in pharmaceutical companies, clinical research organizations, medical writing 
companies (commonly referred as MedComms), publishers, universities, or can also work 
as freelancers. The type of documents will depend on organization objectives; freelancers 
and MedComms often cover a broader spectrum of documents and services.  
As suggested by the diversity of documents, a job in medical writing is not necessarily a 
writer position. Companies may also employ Editors (for copy-writing and proof-reading 
activities), Project Managers (and other leadership positions) and Account Managers. The 
functions also vary with the job task and setting, but generally include (17): 
 Input in scientific documents and reports destined to all audiences types. 
 Consultancy to clients and colleagues on templates, regulations, branding, quality 
control and marketing materials. 
 Input in pharmaceutical development (trial design, data management and 
statistics, product marketing, etc.). 
 Team building and communication activities, and interaction with 
clients/investigators. 
This multiplicity of functions is handy to pharmaceutical and communication companies, in 
which medical writers often grow into leadership positions. But to achieve it a medical 
writer needs to have a diverse set of skills. It is generally expected that, beyond writing 
capabilities and health sciences background, the writer is proficient in: statistical analysis, 
data management, publishing and regulatory requirements, computing (sometimes 
including programming languages), editing, proofreading, design, and soft skills for team 
work. An eye for detail is an often request in job offers. Writers are expected to produce 
flawless text with minor need for revision—a draft is perceived as a final document that 
needs only approval. Skills in editing and proofreading are therefore essential. 
Proofreading is the activity of finding inconsistencies or errors; editing refers to correcting 
and improving the readability of a document; medical writers often do both tasks and the 
difference is not always clear. Nevertheless, editing and proofreading refer to quality 
control of the documents. Soft skills (which are not often trained) are also vital and 
deserve managers’ attention when come to reinforce the medical writer pivotal role. 
Recently, McPhail et al (17) recommended the involvement of medical writers in the 
review of the Statistical Analysis Plan (SAP). The authors argue that this involvement 
benefits both statisticians (identifying errors or gaps) and the writers, which knowing the 
SAP will produce a faster a more accurate report. They suggest that the writer should be 
attentive to: 
 Consistency with the study protocol and completeness. 
 Statistical methodology and how data will be handled.  
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 Comprehensibility and clearness of the statistical methodology for all study 
variables. 
 Outputs contents (tables and listings) that will be at the core of the final study 
report.  
 Grammatical or spelling errors. 
EMWA characterized the activity of freelance writers in 2 surveys in 2003 and 2007 (18, 
19). The most common types of activities were writing, editing and translation (occupying 
respectively 67%, 18% and 11% of the work-time: 2007 data). The most frequent type of 
documents is related to pharmaceutical drug development (41%) followed by scientific 
articles (35%) (18, 19). 
Metrics is a very sensible topic when comes to medical writing. The business world needs 
metrics, and tangible metrics are essential for making managing decisions. Kingdom (20) 
reports some possible metrics: number of documents written, average time to produce a 
document, number of papers published, number of citations of a paper, and number of 
quality control findings. But although the activity is possible to measure—to some extent—
it is important that senior management considers more than numbers to make it tangible. 
For example the average time to produce a document is highly dependent on the difficulty 
and length of the document (and may be dependent on input from third parties).  Good 
writers enjoy learning from the quality control process: it is intended as a cycle to improve 
a document. If it becomes a tool for measuring writing performance, that tool can break 
teams and destroy the true aim of the process. Managers must consider all the possible 
alternatives before imposing strict metrics to writers (20). 
1.3.3 Language 
As we dig deeper in scientific literature the importance of English becomes evident.  
Hikamaru Sano (21) went further reporting in an article the growing importance of English 
since 1961 in one of the largest chemistry databases (Chemistry Abstract file). Figure 3 
shows an adaptation of data reported in Sano’s article; the trend of language use over 
time in scientific papers. 
This clear trend tends to filter medical writers, which must hold reliable writing skills in 
their native and English language—so, who is favoured by this trend? Native English 
writers have for sure a natural advantage, but this is not always true.  
From Figure 3 we can observe that the growth of English as the language of science is 
not derived from a growth of publications from English natives but rather from the 
decrease of publication in other languages. So, English scientific text written by non-
natives is growing: this fact shapes the English language. English in the sciences is 
becoming more direct, eliminating all the flourish and unimportant wording. In this context, 
non-natives hold an advantage because they know what simple English is because they 
were less exposed to the complex form of the language. The unique scientific language 
has to be seen as an opportunity by non-native medical writers. Eugene Garfield already 
defended this point in 1989 (22), saying that the monolingual English native “…risks being 
left out of the conversation in an increasingly global and multilingual business community”. 
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Figure 3. Proportion of papers published in different languages between 1961 and 2000 in 
Chemical Abstracts Service database: adapted from table 1 in (21). 
1.3.4 Authorship 
Authorship, ghost-writing and guest-authorship are big issues in medical writing. Ghost-
writing refers to individuals that although making significant intellectual contributions are 
not included in the author’s list. Furthermore in ghost-writing the writing contributions (as 
technical service) are also not acknowledged. Guest or honorary authorship is intrinsically 
connected with ghost-writing (23, 24). Guest-authorship refers to the practice of including 
authors, which do not qualify as author, to enhance the manuscript reputation or to 
increase the guest’s number of publications (23-26).  
ICMJE guidance (13) refers that authorship criteria should be based on (to classify as 
author all the bellow conditions should be met):  
 “substantial contributions to conception and design, acquisition of data, or analysis 
and interpretation of data; 
 drafting the article or revising it critically for important intellectual content; and  
 final approval of the version to be published.” 
Harvard University (27) presents 6 criteria to guide authorship attribution, from which the 
following is relevant to medical writing activity: “Everyone who is listed as an author 
should have made a substantial, direct, intellectual contribution to the work. For example 
they should have contributed to the conception, design, analysis and/or interpretation of 
data. Everyone who has made other substantial contributions should be acknowledged. 
(…) provision of technical services, patients, or materials, while they may be essential to 
the work, are not in themselves sufficient contributions to justify authorship”. 
Both guidelines appeal to the responsibility of the author and the distinction between 
technical and intellectual contributions. If the medical writer is contracted he passes the 
responsibility and final approval to the sponsor. So the responsibility clause is often 
consensual—the technical writer is not responsible and therefore does not qualify as 
author. The main issue, and source of debate, is in how to distinguish between technical 
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and intellectual contribution. The writing process encloses a natural intellectual 
contribution; it shapes ideas and transfers knowledge. The extent of the outline and 
content control by the author (that is not only a guest) and the sponsor, will dictate the 
difference between intellectual and technical support. If a writer is allowed to contribute to 
the paper in constructive way, then that fact should be properly acknowledged and not 
ranked as a service. But even with an intellectual valid service, the responsibility clause is 
not valid for medical writers, so they do not qualify as authors (28).  
 shows the process of ghost-writing and guest-authorship and the control by 
pharmaceutical industry sponsor (34). It is worth to note that this figure shows the 
fraudulent and non-acknowledged version of the process: if the author outlines the article, 
and the medical writer only does an acknowledged technical service, the process is valid 
and ethical.  
Stephanie Phillips (29) ran a survey in members (N=61) of the American Medical Writers 
Association involved in regulatory writing that could potentially involve bad authorship 
practices. The author found that: in research articles 70% of the writers were involved 
after development of tables and figures and 5% of the participants were only involved after 
development of the first draft (outline); in review articles, 75% of the authors were involved 
before the outline development. Furthermore, the participants estimated that in the outline 
process the authors controlled 51% of the content, the pharmaceutical company 19% and 
the writer 32% (average values) (29). Acknowledgement of the service was more frequent 
in pharmaceutical companies (61%) than in MedComms (18%) (29). 
Other study, from Gøtzsche et al (30), reported alarming numbers of ghost-writing. The 
authors investigated 44 trials and found evidence of ghost-
writing in 33 (increasing for 40 when authorship was 
substituted by acknowledgement). However, in this study, 
qualification as author was defined by the following 
functions: writing of protocol, perform statistical analysis, or 
writing of the manuscript. Other authors (31) discussed that 
these findings are highly debatable due to the definition of 
author being broader than the one used by the ICMJE (13). 
Nevertheless other authors also point to a prevalence of 
guest-authorship in articles published in peer-reviewed 
journals (32, 33). 
Studies on guest-authorship and ghost-writing should follow 
the most accepted standards for authorship (ICMJE or 
Harvard University) and be conducted by transparent 
methodologies. A key message is that the medical writer is 
providing a service, thus the final use and responsibility of 
the result of that service—the manuscript—is of 
responsibility of the client. By current guidance, the 
medical writer should be acknowledged but do not 
qualifies as author.  
 
Figure 4. Fraudulent role of the 
Medical Writer (MW) in ghost-writing 
process. Adapted from figure 1 in 
(34). 
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2 ARC Publishing: the methods 
ARC Publishing is a communication agency tailored for serving healthcare professionals. 
It was developed keeping in mind the difficulties in conciliate the clinical practice and 
research tasks. Those difficulties arise from the lack of time of clinicians that are too busy 
and often work extra hours, but also from the lack of knowledge in clinical research 
methodologies (often non-lectured during medicine courses).  
This context presents a market opportunity to provide specialized services to a niche of 
professionals. Simultaneously it responds to a crescent need in medical writing from 
pharmaceutical industry. The following sections present the mission of ARC Publishing, its 
services and the methods (workflow) employed; it is also included a short description of 
the educational activities performed during the internship. 
2.1 Mission 
“The ARC Publishing mission is to provide superior medical writing, statistics and 
publication services, helping you to get out the most of your work, to enhance your 
reputation among peers, and transfer to society the best of your knowledge”. 
The mission statement transcribed above was developed during the internship and 
transmits ARC’s essential points of action. The short-term goal is to help clinicians to raise 
the impact of their work: this is accomplished by providing medical writing, statistics and 
publication services. But also to help clinicians transfer their knowledge, which can be 
processed in 2 directions: from healthcare professionals to the society, in form of 
publications, or dissemination; and from society to healthcare professionals, in form of 
medical education programs. The last direction is expected to close the loop, generating 
outputs but also providing inputs—and to select those that are meaningful for the practice 
of medicine. With this information loop it is expected to provide a platform for scientific 
sharing and development, and also to increase the professional’s reputation. 
2.2 Services 
As referred above, the main services of ARC Publishing are related to medical writing, 
statistics, publication and educational activities. Although they withhold the same 
importance and were all part of my internship, I describe further the medical writing 
services. Medical writing services are diverse and directed for different audiences thus 
may have multiple formats, which requires a more detailed description. The following 
sections describe each of the ARC Publishing services. 
2.2.1 Medical writing 
Medical writing services are directed for 2 main costumers: healthcare professionals 
(private clinicians) and organizations. Within healthcare professionals 2 profiles can be 
distinguished: clinicians that need support in analysis and reporting their work, and 
clinicians that need writing support for initiating their scientific work (e.g. protocol and 
regulatory submissions consultancy). 
The analysis and report for clinicians includes, but it is not limited to, the following type of 
documents: 
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 Manuscripts for peer-reviewed journals. 
 Abstracts for congresses or proceedings books. 
 Poster presentations.  
 Oral communications. 
 Book chapters. 
 Academic Thesis. 
The support for study initiation for healthcare professionals includes, but it is not limited to, 
the following type of documents: 
 Study protocol, including the SAP and the informed consent. 
 Ethics committee and regulatory applications. 
 CRFs, printed or electronic versions. 
 Study database and codebooks. 
 Statistical report. 
The medical writing services for organizations are aligned with needs of pharmaceutical 
and medical device industry in Portugal. The services are related to the non-regulatory 
part of medical writing. Regulatory writing is a service that has higher demand by the 
innovative industry, which (unfortunately) does not have a strong presence in Portugal. 
The writing of regulatory documents is also inserted in a competitive and highly 
bureaucratic environment that can present impracticable market barriers for start-up 
companies. Therefore ARC Publishing services for organizations are focused on the 
following documents: 
 Translations of clinical study documents, from Portuguese to English or from 
English to Portuguese. 
 Scientific manuscripts, posters, oral communications or any other form of results 
communication. 
 Online scientific materials. 
2.2.2 Statistics 
Statistical services are directed primarily to private healthcare professionals. The intent of 
statistical services is to provide more than an analysis solution: aiming to plan the study 
as well. A planned statistical approach reduces the need for post-hoc analysis and allows 
the sample size calculation. Consequently, the investigator is less prone to waist 
resources with inadequate sample sizes and inefficient statistical analysis. 
The analysis of scientific data is performed following SOPs, which include decision trees 
that adapt the analysis to the data and research question (those SOPs were part of my 
internship objectives).  
2.2.3 Publishing 
The divulgation of knowledge generated by healthcare professionals is a crucial part in 
ARC’s mission. Publishing services aim for that purpose. Because English is (as seen 
above) the language of science, it is always recommended for the clients to write and 
publish in English, maximizing the impact of their work. The publications although thought 
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global, are meant to act local. Scientific journals and books published in Portugal are more 
likely to impact Portuguese audiences: students, pharmaceutical industry, healthcare 
professionals and key opinion leaders. 
The publishing service includes the steps of editing, publishing (proof-reading, formatting, 
and copy-rights handling) and dissemination. The formats may range from books, 
scientific journals, conference proceedings and newsletters. Services related to scientific 
journals also include the development of editorial board, review board, websites, and 
handling of manuscripts and communication with authors. 
2.2.4 Training 
ARC publishing provides training in medical writing, statistics and clinical research 
methodology. The idea behind training services is to provide tailored content to adapt to 
audience needs. The courses are mainly organized for medical educational activities 
(often sponsored by pharmaceutical industry) and for staff training to enhance the 
efficiency of an organization. The methods of teaching may need also specific (tailored) 
approach, e.g. e-learning short courses with video-support. 
The objective of training services is to provide a course that will allow the participants to 
apply the materials in daily activities. For example in statistical courses taught to an 
audience with non-mathematical background, the focus is on teaching the participants 
how to decide which statistical methodology to apply and how to apply it using user-
friendly software. 
2.3 Workflow 
2.3.1 Virtual team and parallel working 
The workflow at ARC Publishing was thought to optimize the work by 2 persons. But it is 
scalable, i.e. it can include more workers. When evaluating the task size and complexity, 
the main issue is to calculate the optimum number of staff to work on the project 
(resources): more members will likely generate more diverse inputs and grant project 
continuation; less members will generate a less bureaucratic and consistent project—to 
find a right balance it is important to be attentive to the specific needs of the document. 
For ARC’s tasks, 2-person teams were judge as optimum to cover the services that are 
part of the portfolio.  
ARC is based on the new paradigm of virtual teams. A set of informatics tools (specified 
bellow) simplifies the virtual work. In specific tasks virtual interaction can be more effective 
than face-to-face interaction. Although apart, the workers are in constant communication, 
benefiting from the isolation for writing (writers are often annoyed by interruptions) and 
from the scheduled communications periods. 
2 persons working in the same project already generate a degree of parallel workflow. As 
shown in Figure 5, the time-savings are considerable when a team of 2 persons works in 
parallel. Parallel work has more advantages than time-savings. It allows a stronger outline 
component. When 2 persons think the outline, it becomes more robust and less prone to 
modifications—furthermore, if the workers have complementary skills the project will 
benefit from different perspectives. It can also be more consistent since the document 
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story is shared and understood by both workers. Other advantage of working in parallel is 
to reduce the dependency of the individual. In this way a team shortage will produce only 
a small impact on the final product delivery time and quality. 
 
Figure 5. Time saving in parallel workflow compared to sequential workflow for writing a scientific 
manuscript; the team size is 2 (workers 1 and 2); and the order (sequence) of tasks is purely 
illustrative. 
2.3.2 Software 
ARC Publishing collaborators need to work with a broad range of computer software. To 
meet the service and workflow needs it is necessary publishing/medical writing, statistics 
and project management software. On top of the task-specific software, other informatics 
tools are necessary to manage the communications and data transfer. 
Publishing and medical writing services use heavily common word processor and slide 
presentation software (Ms Word® and PowerPoint®). For better layouts and to publish final 
versions of documents we opt for InDesign®. InDesign allows to more efficiently align the 
text in various formats (e.g. it is useful to flow text in multi-row formats for scientific articles 
layout). To generate high quality figures we opt for Gimp®. Gimp can be seen as the open-
source version of Photoshop® from Adobe. 
Statistical analyses were performed in SPSS®. SPSS allows investigators the commodity 
of a non-programming environment, being user friendly and maintaining scientific 
consistency. To obtain certain types of figures (e.g. pharmacokinetic graphs) more flexible 
software were used as Ms Excel® and Graphpad Prism®.  
The project management and communication software is critical to virtual teams. To keep 
track on tasks, and to monitor their priority/completeness we used the TeamBox® 
software. TeamBox is free of charge for a small number of projects and a small number of 
users (ideal in the start-up company context). TeamBox also allows the integration of file 
sharing software as Google Drive® and Dropbox®. The crescent number of 
videoconference and cloud-based office software also favours virtual teams. Our choice 
for videoconference was Skype®; to simultaneously process text we chose Google Drive. 
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Google Drive allows the users to view real time edits from partners, which is an effective 
method to discuss and draft manuscripts outlines while in voice conference. 
To manage the submission and peer-review of manuscripts, in-house software was 
created and named Manuscripts. More details of the development and features of 
Manuscripts are available at section 3. 
2.3.3 Quality control in medical writing 
One of the tasks of the internship was to create and implement a quality control system. 
Although not in writing format, some quality guidance was already in place. Medical 
writing quality control can be seen as a double-step process: self and external quality 
control. Self quality control refers to the process of producing the best draft possible. This 
quality control (that can also be regarded as revision) should preferably take place after 
some time (at least a good night of sleep) of writing the first draft—giving the possibility to 
the writer to acquire some mental space from the freshly done text. External quality 
control assures that the writing is flawless. Writing is a form of transmitting knowledge and 
it also suffers from what is commonly referred as curse of knowledge—that can be defined 
as the difficulty of after learning return to the non-knowledge perspective (the previous 
step) and reconstruct the learning process. External validity is also crucial to guarantee 
that the writer does not skip any important piece of information for the reader, and that the 
draft is free of mistakes and consistent in style.  
2.3.3.1 SOP structure 
Although a clear structure for SOPs was not in place at the start of the internship, training 
was provided in how to deliver consistent SOPs. The SOP development was also part of 
the first year master’s course in the module clinical pharmacology. The course included 
the general rules of writing SOPs and part of evaluation work was to create a SOP for 
writing the clinical study protocol. 
In summary, the general rules considered for SOP development were to: 
 Know the SOP objective and have a clear work methodology apprehended. 
 Put in place a quality control process, with SOP approval and version control. 
 Use a template that is based on the following sections: 
o Purpose 
o Scope 
o References 
o Responsibilities 
o Procedures 
o Appendices  
 Use flowcharts and diagrams to explain complex procedures. 
2.4 Sponsored training  
On top of the training provided during the first year of the master program in 
Pharmaceutical Medicine, ARC Publishing also sponsored a course in Project 
Management. ARC also allows the employees to seek for free web-based formation. 
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Those formations were conducted during the internship and were essential to complement 
the on-job training. 
2.4.1 Project management: interpersonal skills 
The course “Project management: interpersonal skills” is part of an optional subject of the 
master degree in pharmaceutical medicine. Since it was an extra-curricular (and optional) 
course, ARC Publishing sponsored my participation. 
The course was fundamental to better understand the subtle role of interpersonal skills 
when managing a project. It presented 8 interpersonal skills: leadership, team building, 
motivation, communication, influencing, decision making, negotiations, and 
political/cultural awareness. All the skills presented are essential for team members in 
organizations. Even for small companies, the training in interpersonal skills is very 
important to alert worker’s senses for the team needs. 
The course allowed me to practice teambuilding through creative group exercises, in 
which the dialogue and empowerment was fomented. It also provided a review on the 
importance of communication for project success. The course made use of guidelines and 
structured approaches to soft skills. The participants were able to use those guidelines for 
positive communication (influence), effective negotiations, conflict management, and 
decision-making. Issues of power and relationships were also part of this course: e.g. how 
to apply models of leadership and motivation. 
2.4.2 Web-based training 
Massive Open Online Courses—as Coursera.org and Edx.org—are practical solutions for 
start-up companies to solve part of the training needs. It also helps to keep the employees 
motivated, allowing them to pursuit intellectual enrichment during some working hours. 
The course offer is becoming more and more diversified with a crescent number of 
universities joining Coursera and Edx initiatives. Table 1 shows the courses in the areas 
of writing, statistics and pharmaceutical medicine since September 2012. From those 
courses, I successfully (every course has an evaluation component) completed: 
 Writing in the Sciences from Stanford University. 
 Passion Driven Statistics from Wesleyan University. 
 Data Analysis from Johns Hopkins University. 
 Vaccine Trials: Methods and Best Practices from Johns Hopkins University. 
 Drugs and the Brain from California Institute of Technology. 
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Table 1. Massive Open Online Courses available in Coursera.org and Edx.org relevant to ARC 
Publishing activity. The courses in the table were available since September 2012. 
Writing courses University 
Writing in the Sciences Stanford University 
Clinical Terminology for International and American Students University of Pittsburgh 
Crafting an Effective Writer: Tools of the Trade Mt. San Jacinto College 
English Composition I: Achieving Expertise Duke University 
Writing II: Rhetorical Composing Ohio State University 
Statistics and Data Management courses University 
Statistics One Princeton University 
Statistics: Making Sense of Data University of Toronto 
Mathematical Biostatistics Boot Camp Johns Hopkins University 
Passion Driven Statistics Wesleyan University 
Introduction to Statistics (3 courses)a University of California, Berkeley 
Computing for Data Analysis Johns Hopkins University 
Data Analysis Johns Hopkins University 
Data Management for Clinical Research Vanderbilt University 
Health in Numbers: Quantitative Methods in Clinical & Public 
Healtha 
Harvard University 
Network Analysis in Systems Biology Mount Sinai School of Medicine 
Other courses related to Pharmaceutical Medicine University 
Drug Discovery, Development & Commercialization University of California, San Diego 
Take Your Medicine - The Impact of Drug Development a University of Texas, Austin 
Fundamentals of Pharmacology University of Pennsylvania 
Introduction to Pharmacy Ohio State University 
Vaccine Trials: Methods and Best Practices Johns Hopkins University 
Vaccines University of Pennsylvania 
Drugs and the Brain California Institute of Technology 
Neuroethics University of Pennsylvania 
Generation Rx: The Science Behind Prescription Drug Abuse Ohio State University 
Health Informatics in the Cloud Georgia Institute of Technology 
Interprofessional Healthcare Informatics University of Minnesota 
Epidemiology: The Basic Science of Public Health University of North Carolina 
Epidemics - the Dynamics of Infectious Diseases Pennsylvania State University 
Rationing and Allocating Scarce Medical Resources University of Pennsylvania 
Global Health: Interdisciplinary Overview University of Geneva 
Principles of Public Health University of California, Irvine 
aCourse in edx.org; the majority of the courses are from coursera.org 
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3 Editorial Management: the results 
3.1 Publications (open-access) 
3.1.1 International Journal of Clinical Neurosciences and Mental Health 
The IJCNMH is an open-access journal published online by ARC Publishing. It aims to 
publish high quality articles in the areas of Psychiatry, Mental Health, Medical Psychology, 
Neurosurgery and Neurology. The Editor-in-Chief is Rui Coelho (MD, PhD), assisted by 3 
Associate Editors for each medical specialty: 
 Rui Mota-Cardoso, MD PhD (Psychiatry and Mental Health)  
 Carolina Garrett, MD PhD (Neurology)  
 Rui Vaz, MD PhD (Neurosurgery) 
Our aim was to: select the members of the editorial board to be invited; develop a 
database of contacts for dissemination and marketing activities; plan (and manage the 
production) of the journal website and peer-review platform; and write guidelines for 
authors and reviewers, and website contents. 
One of the very first tasks—with the definition of the journal’s scope in hand—was to 
define the types of articles the journal will publish. The categories list and a brief 
explanation of each article type can be seen in Table 2. 
Table 2. Description of the categories published by the International Journal of Clinical 
Neurosciences and Mental Health. 
Categories Content overview 
Original research 
articles 
Original work reports within the scope of the journal. The manuscripts should 
follow author’s instructions and CONSORT or STROBE guidelinesa (when 
appropriate). 
Reviews Review articles within the scope of the journal (by invitation or unsolicited). 
Drug reviews Review articles on central nervous system related drugs (by invitation or 
unsolicited). 
Case reports Highly meaningful case reports, including major educational content or major 
clinical findings.  
Case snippets Case snippets are short case reports, describing a diagnosis or therapeutic 
challenge. 
Viewpoints Viewpoints provide an expert opinion on important topics for medical research 
or practice (including social and policy aspects); it encourages dialogue and 
debate. 
Letters to the 
Editor 
Letters to the Editor share views on published articles; it can also present 
materials (within journal’s scope) insufficient for an original research article. 
Editorials and 
guest editorials 
Authors are invited by the Editor-in-Chief to comment on specific topics and 
express their opinions. 
a CONSORT: Consolidated Standards of Reporting Trials; STROBE: STrengthening the Reporting 
of OBservational studies in Epidemiology; 
 
The next step was to identify the stakeholders of the project. In that group we included 
potential editorial board members, reviewers, authors, medical societies, patient groups 
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and educational institutions. The identification of stakeholders’ contact information (for 
dissemination and journal development activities) was performed via internet 
benchmarking and generated a large database of contacts. The next section explains the 
process to select and invite an editorial board based on the contact list. 
3.1.2 From a contact list to an editorial board 
With a contact list in hand and some key opinion leaders pre-identified, the job was now to 
select and invite members for the journal’s editorial board. Editorial board members 
provide overall guidance on the IJCNMH development. Members will receive periodic 
correspondence documenting the journal activities and will be asked to provide their 
feedback. IJCNMH philosophy is that editorial board members’ contributions are the key 
to improve the quality and reputation of the journal. Engaging board members may also 
edit and approve manuscripts on their expertise area. 
The selection of the editorial board members was based on expertise and scientific 
contributions in the field of Clinical Neurosciences and Mental Health, namely: editorial 
experience, relevance of their professional background and the authorship of papers in 
peer-review journals and of book chapters. The target number of editorial members was 
estimated between 30 and 60, with a maximum of 20 specialists for major scientific area—
Psychiatry and Mental Health, Neurology, and Neurosurgery. The maximum proportion of 
Portuguese members was set to 20%. After selection, by the Editor-in-Chief and 
Associate Editors, the members were formally invited by e-mail. The invitation included 2 
steps when mediated by Associate Editors, firstly by an informal invitation and secondly 
by formal invitation by the Editor-in-Chief. This stepwise approach was performed to 
achieve a first nucleus of editorial members, which allow us to present a more solid 
project to potential editorial members that did not have a close professional relationship 
with the Editor-in-Chief or Associate Editors (the majority of the potential members were in 
this category). In the described process I built the contact database and wrote the formal 
letters and e-mails of invitation.  
The contact list included experts (approximately 800) in several areas, including: 
neurosurgery, dementia, movement diseases, neuro-image, addiction, affective disorders, 
bio-psychiatry, child psychiatry, community and social psychiatry, forensic psychiatry, 
genetic and psychiatry, post-traumatic stress, psychopathy, psychosomatics, 
psychotherapy, schizophrenia, sexology, stigma, and neuropsychiatry. Until March 2013, 
33 experts accepted our invitation and are members of the editorial board of the 
IJCNMH—please refer to the Appendix 7.4 for the full list of members and their expertise 
areas. The majority of the editorial board members currently work in Europe (73%). 
Nevertheless only Asian continent is not represented; geographical locations include 
North America (N=4; 3 from USA and 1 from Canada), South America (N=2; from Brazil), 
Oceania (N=2; from Australia) and Africa (N=1; from Morocco). European members’ 
geographical distribution is show in Figure 6. The number of Portuguese members 
accounted for roughly 1% (N=2, with an additional Portuguese member working in 
Netherlands). The majority of the editorial board members are from UK, Italy and Spain.  
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Figure 6. European members (N=24) of the editorial board of the IJCNMH per country. 
The majority (64%) of the editorial board members hold a MD, PhD degree, which is a 
common combination of degrees in physician scientists (Figure 7). Since the selection of 
members was qualitative, the number of publications was not the main factor of choice 
and it is not explored in this report. Using the Appendix 7.4 information it is possible to 
verify that board members combine their academic degree with extensive research and 
editorial experience, holding an impressive number of publications in peer-review journals. 
 
Figure 7. Academic degree distribution of IJCNMH editorial board members. Doctor of Medicine 
(MD); Doctor of Philosophy (PhD); combined MD and PhD (MD, PhD) doctoral degrees; 
3.1.3 Author and reviewers guidelines 
A major task in journal development is the writing of guidelines for authors and for 
reviewers. The complete set of author’s instructions is available in the Appendix 7.1. The 
reviewers’ guidance is not transcribed to this report since it is part of the journal’s internal 
documents: only a brief overview of peer-review process and of the general guidance is 
provided. In the Appendix 7.2 it is also included a template for cover letter developed 
during the internship. 
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3.1.3.1 Review process and guidelines 
We adopt the most usual peer-review process (presented in Figure 1) in double blind 
mode. The reviewers are blinded to author’s identity and the authors have only access to 
reviewer’s comments through editor’s feedback. To assure a consistent review process it 
is asked the reviewers to use a template and evaluate a set of points—in line with ICJME, 
Consolidated Standards of Reporting Trials, and STrengthening the Reporting of 
OBservational studies in Epidemiology guidance—and to give their feedback in terms of: 
minor concerns; major concerns and overall assessment (accept the manuscript as 
submitted; accept after revision; resubmit after major revision; reject). This feedback is 
provided in a template form that was developed during the internship. 
3.1.3.2 Authors’ guidelines 
Guidelines and templates for authors are based on ICJME guidance. Furthermore the 
choice of reference style was of Vancouver style, because it is the current standard for 
medical journals and it is intimately connected with the ICJME formation: the Vancouver 
group (1978) was formed by a small group of medical journals editors; it adopted (1979) a 
reference format developed by the National Library of Medicine—the Vancouver style; that 
small group of Vancouver editors grew into what is currently the ICJME (13). 
The set of instructions for authors (full text in appendix 7.1) is structured in the following 
sections: type of papers, manuscript submission and overview of the editorial process. In 
the section type of papers the authors are instructed about journal’s scope and which type 
of documents will be considered for publication. The section of manuscript submission 
details the submission process, including: templates to be used, manuscript preparation 
(length, format, etc.), information to be included, and submission checklist. In the last 
section of the instructions we can find an overview of the editorial process including the 
process to appeal editor’s decision. 
The set of templates available for authors include also the cover letter template (in 
appendix 7.2) and the conflict of interest disclosure form from ICJME. The cover letter 
template is intended to streamline author-editor first interaction. It also includes 
statements about the originality, authorship and ethics, which replaces the use of multiple 
forms. Due to the importance of disclosing interests in medical journals, we adopt the 
standard disclosure form from ICJME (available at the ICJME’s website) (35). 
3.1.3.3 Templates to communicate editorial decisions to the author 
The internal guidelines on communication with authors include a large group of text used 
as standard replies for the outcomes of the review process. Those texts function as a 
template to be altered by the editor. It allows to accelerate the editor’s feedback times and 
to improve journal image. The templates include emails for the following outcomes: 
manuscript accepted, manuscript to be reconsidered after author’s revision, manuscript 
rejected after peer-review round, and manuscript rejected immediately. For immediate 
rejection there are sub-templates for each of the most common reasons to reject a paper: 
 The research topic is outside journal’s scope.  
 The research does not provide meaningfull novelty when compared to previous 
publications.  
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 The research study is unlikely to represent any clinical/scientific practice (and/or 
lacks external validity).  
 The study design is not suited to answer the research question and therefore lacks 
scientific validity.  
 The research presents a major methodological error (e.g. insufficient study 
population, inadequate study design).  
 The report needs major revisions in English grammar and scientific writing style.  
3.1.4 Website and peer-review platform 
This section of internship results is referent to the development of the websites related to 
the IJCNMH. The websites can be found in the following addresses: 
 https://ijcnmh.arc-publishing.org/ (IJCNMH main website). 
 https://ijcnmh.manuscripts.arc-publishing.org/ (submission platform). 
ARC subcontracted an Information Technology (IT) company to develop the journal 
website and the article submission platform. To manage the production and test of the 
websites I developed the set of requirements and worked closely with the IT project 
manager. Since the company was not experienced in testing websites for publication 
purposes, I also developed a test plan to monitor quality. 
Requirements for the journal website included: 
 Back-office to handle site information and image. 
 Database for handling articles in pdf format, categorized by issues and type of 
article. 
 User registry system, which is shared with the submission platform. 
Requirements for the submission and peer review system included: 
 User registry system. 
 File handler and communication interface from author’s perspective. 
 File handler and communication interface from reviewer’s perspective. 
 Control and managing of process and communications from editor’s perspective. 
 Capacity to generate new installations (new instances of the program to be used 
by other ARC’s journals or clients). 
The development of the website registered a considerable delay in production. The IT 
company estimated (and budgeted) a development time of 1 month. The first version of 
the web-site was delivered in the second month and the final version was only approved 
in the sixth month. The major issues found were inconsistencies and programming errors, 
which required several cycles of quality control. 
The submission and peer-review platform was named “Manuscripts” and it is defined as a 
web-service optimized for managing scientific materials, capable of handling academic 
journals and conferences’ publications. After registration, the user can act as an author or 
a reviewer. Both the author and reviewer menus allow the user to keep track on their 
submissions/revisions. The editor has the choice to allow or forbid re-submissions of an 
article, and when re-submitted it can go through the same or through new reviewers. 
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Figure 8 shows a screenshot (taken from the Manuscripts user guide) of the software. 
Since the IT company was not familiar with development of manuals for scientific 
audiences we decided to write those on our own. The manuals were written by the 
medical writer trainee; I revised for content and for writing quality. It is a set of 3 
documents that includes the guides for Author, Reviewer and Editor. Since it is a long 
document, with a large number of images and examples to help the user, it was not 
included in Appendices. Nevertheless the guides are available at the IJCNMH website. 
 
Figure 8. Example of menu from Manuscripts (submission and peer-review platform), image 
available on the Author guide. 
3.1.5 Graphical identity and article layout 
The IJCNMH graphical identity was developed together with a design and IT Company. 
The IJCNMH logo (top left corner at Figure 9) emphasis the main areas of publication 
“Clinical Neurosciences and Mental Health”, shortening the otherwise long name. The 
website design choice was based on the usability by clinicians, giving preference to high 
contrast text and white background. Those preferences allow a clean design, which is also 
better suited for printing. The logo and website format were approved by the Editor-in-
Chief and Associate Editors. 
To launch the websites and promote submission to IJCNMH, we prepared a call for 
papers newsletter. This newsletter was published in the home page of IJCNMH website 
(Figure 9), it was distributed by email, and it was published as an advertisement in the 
2013’s March Edition (nº 54) of Nortemédico (magazine published by the north section of 
the Portuguese Medical Association—Ordem dos Médicos).  
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The article layout (In Appendix 7.5) was developed using InDesign. It includes the layout 
for the first page, abstract, body and references. The first page contains the journal logo, 
journal section, article title, Digital Object Identifier number, author’s names and 
affiliations, and a structured abstract (in 2-columns format). The body is divided in the 
main sections and sub-sections. The body header contains the running title (pair page) 
and the first author name (odd page); the footer holds the page number, the ARC 
Publishing logo (pair page) and the IJCNMH logo (odd page).  
 
Figure 9. Screenshot (April 2013) of the IJCNMH website home page: call for papers. 
3.1.6 Open-access and copyright license 
IJCNMH adopted an open-access model for copyright management. All publications are 
available for free to every user in the internet. The access to the scientific materials is not 
subjected to user registration or to subscription of journal newsletters. The publishing of 
materials is not subject to payment of any fees by the author. We believe that this model 
is the most effective for a new peer-review journal, which despite being too recent to be 
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indexed and receive an impact factor, allows the authors to disseminate their results 
throughout the scientific community. 
We implement a copyrights license identical to the Creative Commons Attribution License 
- cc.3.0. The authors are the copyright holders but grant everyone (a third party) the right 
to: display, copy, and distribute the work; make derivative works; and make commercial 
use of the work. Nevertheless the third party must reference (give credit) the original 
author, and disclose the license terms for any reuse or distribution. The full license 
agreement is available in appendix 7.3. 
3.1.7 Edition of books and book chapters 
During the internship I participated in the edition of books and sections on pharmaceutical 
medicine and drug development, and on photodynamic therapy. The photodynamic 
therapy book section was a minor activity, consisting in proofreading and editing of a small 
book section. The major activity regarding book edition was related to the edition of a 
book in the pharmaceutical medicine topic. The draft book sections were written by 
medicine students, as part of a work from a medicine course, and were edited by ARC 
Publishing. Our job was to edit the sections for consistency in content and writing style. 
The total work duration was of 1 month (15 book chapters), in which we (me and the junior 
writer) performed a double revision—each editor revised the first revision from the 
colleague. This was one of my last tasks at ARC Publishing and because of that I did not 
follow the next planned publication steps: communication with authors, proofreading and 
copyright management.  
3.2 Medical writing 
3.2.1 Scientific manuscripts 
3.2.1.1 Writing of scientific publications for pharmaceutical industry (bipolar disorder). 
During the internship we wrote a paper on bipolar disorder. This paper was based on 3 
clinical study reports. The objective was to write a manuscript that combined the results of 
a drug tested in bipolar disorder. The project was divided in the following steps: 1) outline 
of the manuscripts, 2) selection of the tables and figures from each study report, 3) 
combination of information in new figures, 4) writing of the first draft, and 5) manuscript 
revision. 
Writing of articles based on study reports it is per se a demanding task, but this one 
presented additional constrains: it was a combination of studies (in which the report was 
not consistent and some variables were missing), and it was a report of negative results. 
As seen in the introductory section, reports from negative results suffer from a publication 
bias. The task was performed by 2 writers in 4 weeks (this period was not full time, a full-
time equivalent of 0.8 may represent a good approximation). 
3.2.1.2 Statistical analysis and writing (smoking cessation) 
The smoking cessation study aimed to characterize the socio-demographic and 
psychological characteristics of a group of smokers enrolled in an urban primary 
healthcare setting. To this paper I contributed with database recoding, statistical analysis 
(SPSS), and writing of all sections of the manuscript (including figures and tables). The 
main author (general practitioner) collected observational, cross-sectional data from 200 
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smokers and characterized the socio-demographic and smoking habits of 2 health units. 
The Fagerstrom test was used to assess smoking dependence and the Richmond test 
(plus a visual analogue scale) to measure motivation for smoking cessation. The State-
Trait Anxiety Inventory and Beck Depression Inventory were used to assess anxiety and 
depression. To make group comparisons we used Mann-Whitney/Wilcoxon and Chi-
square tests; to test relations between variables we used Spearman’s correlation. We 
concluded that smoking cessation interventions should be tailored for patients’ socio-
demographic and psychological characteristics, and should be promoted as early as 
possible in smokers’ life. 
The study was submitted to an open-access journal but unfortunately was rejected after 
peer-review. To the date no further efforts were made to publish the work since it requires 
major methodology modifications (related to the non-novelty of the scientific question). 
3.2.2 Oral communications: medical writing course 
We developed a medical writing course for use in face-to-face and e-learning activities. 
The course is divided in 10 slide presentations (course topics, Table 3). It includes topics 
on sentence and paragraph level, at document level, reaching also publication and 
presentation management. 
Table 3. Medical writing course topics and summary of the contents. 
Course topic Summary of contents 
Mind the reader - Basic medical writing concepts. 
- Message definition and adjustment to the audience. 
Effective writing I:  
simple and direct English 
- How to cut unnecessary text.  
- Writing in clear and concise English.  
Effective writing II:  
active voice and verbs 
- Importance of the use of active voice in scientific documents. 
- The power and importance of verbs.  
Structure and organization 
(sentence and paragraph level) 
- Punctuation rules.  
- Phrases with parallel structures.  
- Organize, write and craft paragraphs. 
Writing process - Macro level structure of scientific documents. 
- 3 main phases of the writing process.  
- Methodologies to improve writing efficiency. 
Data presentation - Types of data presentation: tables, flow-charts, and graphs. 
- Basic rules for effective data presentations.  
Publication strategy - Defining the target audience and criteria for journal choice.  
- Strategies to improve publication impact. 
Scientific manuscripts - Guidelines and authors’ instructions.  
- Original manuscripts and other types of publications. 
Peer-review process - Submission process and steps of peer-review process.  
- Outcomes of the peer-review process.  
Posters and oral presentations - Basic rules for poster presentations and oral communications. 
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3.2.3 Translations 
Although translations between English and Portuguese are those ARC Publishing is 
specialized, we performed a translation of regulatory documents from Spanish to 
Portuguese. The translation was performed recurring to a professional translator. Our role 
was to adapt and correct scientific terms and verify the consistency of the documents for 
submission to data protection authorities. The Comissão Nacional de Proteção de Dados 
(CNPD) is the Portuguese authority for data protection. 
The list of translated and submitted documents included: study protocol, patient 
information, informed consent, CRFs (patient and investigator version), and contractual 
agreements between hospital, investigator and sponsor. The approval time was of 40 
(working) days, with 7 days of clock-stop in which CNPD asked further clarifications. The 
reply to the clarifications request was also written by ARC Publishing. 
 
Figure 10.  Example of the layout of the Case Report Forms (CRF): report of adverse events due to 
concomitant medications. 
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3.2.4 CRF design 
The design of CRFs can be seen as the most regulatory writing task in the scope of ARC 
Publishing. It is a complex activity that integrates writing and data management skills. To 
streamline the preparation of CRFs we developed templates for a variety of forms, 
including: informed consent, inclusion/exclusion criteria, demography, medical history, 
physical examination, electrocardiogram, vital signs, blood sampling, urine sampling, 
eligibility on admission, drug administration, concomitant medications (Figure 10), and 
study termination. Those forms can be used to gather patient data in the different periods 
of the clinical study: screening, admission, treatment, discharge and follow-up. 
The CRF layout was created in InDesign and allows data entry in printing version and in 
electronic version. The electronic version uses data fields in pdf format and it is 
compatible with the majority of the operating systems (including portable devices). The 
layout was created to reduce the operator error rate, providing a clear and intuitive format 
for entering subject data. 
3.3 Managing activities 
3.3.1 Standard Operating Procedures 
ARC Publishing’s SOPs can be classified as: General Procedure (GP), when defining 
global working rules; Specific Procedure (SP), when describing a procedure in great 
detail; and Operative Procedure (OP), when characterizing a given program/equipment 
and the conditions of its installation, operation, calibration, and maintenance. The 
following include the list (under development) of SOPs: 
 SOP of SOPs (GP)—to establish the process of the preparation, approval, review, 
distribution, tracking, withdrawal, archive and training of every SOP. 
 Information Technologies (GP)—to define instructions to manage information 
technologies, including: security, license management, databases, websites and 
privacy. 
 Manuscripts Website Management (SP)—to instruct workers how to manage 
Manuscripts platform licensing and client installation and interaction. 
 Documentation Management and Communications (GP)—to establish conventions 
for identification of workers, documentation codes, and communication channels. 
 Project’s Workflow (GP)—to define the activities of the project manager and 
workflow for medical writing, statistics and publishing services. 
 Interactions with Clients (SP)—to specify the preferred channels, conventions and 
templates for client interaction. 
 Service Outsourcing (SP)—to establish the selection process, communications, 
confidentiality and quality control for services outsourced to third parties. 
 Statistical Analysis (SP)—to define the standard methodology for choosing the 
adequate statistical analysis for a given data set. 
 Data Management (SP)—to specify internal (data produced by ARC) and external 
(data delivered to ARC) data management tasks, quality control and data base 
lock. 
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 OpenClinica (OP)—to instruct workers how to install, validate, and operate 
OpenClinica (an open-source electronic data capture software). 
 Glossary (SP)—to define medical terms, drugs identifications, and disease 
Identifications standards. 
During the internship we developed a detailed SOP structure (outline), with defined 
processes, and wrote complete versions (in draft) for the: SOP of SOPs; Statistical 
Analysis; Information Technologies; and Documentation Management and 
Communications. 
3.3.2 Marketing materials 
We wrote the marketing text for ARC Publishing’s website, including: mission statement, 
description of each service, and contact information. We also developed the privacy police 
and terms and conditions, which are legal documents crucial to website operation. Privacy 
police includes information on internet cookies (and their use), how we store information, 
how information is used and disseminated, and the user rights. Terms and conditions 
describe the website general provisions, the access to the website and restrictions of use, 
the submissions, security and liability/indemnity, copyrights and trademarks, and the main 
provisions of the governing law. Those documents served as basis for the privacy police 
and terms and conditions of the IJCNMH and the Manuscripts website. 
Newsletters were written to disseminate ARC Publishing services through the potential 
clients. Commercial newsletters were developed in html format by the medical writer 
trainee and I revised for content and design. The trainee also built a contact list (similar to 
the one made for the IJCNMH) in which the main contacts were identified. 
3.3.3 Brand protection 
When developing a new company based on a brand—ARC Publishing—it is important to 
register that same brand to protect and prevent the misuse from third parties. Brands can 
be registered on international or national level.  We decided to register ARC Publishing at 
national level only. The Portuguese entity for brand protection is the Instituto Nacional de 
Proteção Industrial. The registry is submitted online and the cost depends on the number 
of service classes that the brand protection covers. 1 service class may include multiple 
services. The basic registry (1 service class) costs 120€, each additional service class 
costs 30€. The brand can be registered as text, image or mixed (both image and text) 
element. ARC Publishing was registered as a mixed element brand—this way we could 
also include the logo. The protection is valid for 10 years and can be renewed after this 
period. We chose to register ARC Publishing in service class nº 41 related to education, 
training and cultural activities. Inside this service class we selected the services that were 
adequate to the company activity. 
To guarantee that the brand was not already in use, I performed an international and 
national benchmarking of brands using the name ARC. The benchmarking included the 
study of the text “ARC Publishing” and the format of ARC’s Logo. Although some brands 
already held a part of the name (“ARC”), no brand was identified with the complete text, 
and none of the brands with “ARC” on their name were registered for the service class nº 
41. There was no marked similarity between logos. 
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3.3.4 Supervision of medical writing internship 
Training is part of the mission of ARC Publishing, and that is extended to the training of 
new medical writers. In this context I was asked to assist in the training of a junior medical 
writer (September 2012), which major topics of interest (for the trainee and for the 
company) were medical writing and data management. During this report I’ve been using 
massively the word “We”. The use of “We” is related to the preference for active voice, but 
also because all work performed was done with the collaboration of my colleague in the 
medical writer trainee position. 
One of the first tasks was to integrate and understand how to take the most of the junior 
collaboration. The trainee main interests were (apart from writing) the development in data 
management processes. Since I already had some experience with OpenClinica—a fast 
expanding open-source platform for data management in clinical trials—we selected this 
platform for the use in clinical research from investigator initiative. The job of the trainee 
was to install, manage this platform and create the appropriate SOPs. 
Medical writing activities benefited from a common basis of formation we (me and the 
trainee) shared. The first training session in medical writing was during the module of the 
pharmaceutical medicine master program. The second one was an online formation in 
Coursera.org (Writing in the Sciences from Stanford University). The common formation 
and the level of close interaction allowed smooth processes and consistent quality control. 
My evaluation of trainee’s work is extremely positive. He achieved all the internship goals, 
showing professional and efficient solutions to each task assigned. Furthermore the 
trainee was asked to continue as company staff, which is the best indicator of a proper 
developed work. 
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4 Discussion 
The main technical objectives of my internship were to develop the IJCNMH and to 
perform medical writing tasks. Bound with those objectives, and as result of the 
empowerment in the first months, I was invited to actively manage ARC Publishing 
activities and to promote the company growth. Both primary and secondary goals were 
achieved. We were able to build a solid editorial board for the journal and an IT 
infrastructure to warrant the journal publication, manuscript submission and peer-review 
process. As medical writer I participated in the writing of 2 original manuscripts, revised 
and executed statistical methods, edited book chapters, prepared CRFs, and wrote 
instructions for authors and marketing texts (among several other works). In management 
we were able to register ARC Publishing brand, to promote it among our clients and to 
build internal resources (by staff training and quality procedures) to guarantee ARC 
Publishing endures as a reference in medical writing for private clinicians.  
4.1 Comments on publishing results 
The internship was centred in the development of the IJCNMH. Therefore the bulk of the 
work was concentrated on this part. Looking back, in 9 months we were able to identify 
the key opinion leaders in clinical neurosciences and mental health, to invite them to our 
editorial board, to write all the necessary texts for the journal launch and to have the 
journal site and platform in place. All of those activities demanded a high level of 
commitment by the collaborators to surpass the daily challenges.   
To look for contacts in internet, and to comprehensively list their details (contact name, 
surname, institution, address, academic title(s), publications, address, e-mail and phone 
number) was time-consuming. Not every expert likes to expose contact information 
publically, and even those who do, are not always directly reachable by an internet 
search—sometimes it is necessary to dig in the institutions webpages to look for a single 
detail of 1 contact. That detail can make the difference between a successful and failed 
invitation. The selection of experts depended on the richness and organization of the 
database of contacts. First impressions count, and to make them efficient a lot of attention 
was given to the image and contents of journal communication. The editorial board 
invitations texts passed through numerous cycles of revision and the final version was 
revised by all ARC Publishing collaborators and the journal Editor-in-Chief. It was more 
than one “spam” letter version; it was tailored for position and for the existence of previous 
contact from Associate Editors. The final list of the editorial board achieved our objectives: 
more than 30 members in total (and not more than 20 experts by scientific area), a large 
diversity of expertise and geographical locations, and a small proportion of Portuguese 
members.  
The websites texts (marketing, legal and scientific) and the integrity of the informatics 
platform represented also a great deal of effort. We wrote and revise all marketing and 
legal documents (copyrights, privacy police, terms and conditions, etc.) according to the 
best writing methodologies and being always attentive to detail. Although those activities 
were crucial, we allocate more resources to the writing of scientific materials—as the 
instructions for authors and journal templates—and to monitor the quality of the 
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submission and peer-review platform. The instructions for authors follow the highest 
standards of the ICMJE.  
The instructions although revised several times, were also dependent on the development 
of the submission and peer-review platform. Each time the website programmers 
acknowledged a needed change in the original plan (e.g. the impossibility of placing the 
line numbers automatically in the document) it implicated a change in the author’s 
submission workflow. As referred in the results section, the submission platform 
experienced a considerable delay in production. Much of the delay was caused (to our 
benefit) by ARC’s strict quality control and constant test of the several beta-versions. 
Those quality routines test not only the website infrastructure and robustness but also our 
patience and soft skills. 2 users performed the routines independently, with a total 
duration ranging from 2 to 6 hours (depending on the step of the submission/revision 
where the errors were found and excluding the reporting and communication with the IT 
company). Indeed those test routines were not thought to repeat more than 2 times; if we 
anticipated the large delay and problems in website production it would be more fruitful to 
develop automatic routines—out of the scope of my skills and internship goals. But even 
automatic testing routines could not predict all the errors found, which were sometimes 
related with the misinterpretation of our needs as clients. The use of interpersonal skills as 
communication, team collaboration and negotiation were crucial to “survive” to this 
development process. We had to compromise to achieve the best solution possible. 
During my internship it was not feasible to launch the first edition of the IJCNMH. 
Meanwhile (April 2013) the journal has emitted a call for papers, which in collaboration 
with the papers submitted by the editorial board research teams, will surely make the first 
edition possible in the following months. Any new open-access journal strives to have a 
steady publication output. The regularity of publication for 2 years is crucial to allow the 
IJCNMH to be indexed in the major scientific databases. 
4.2 Comments on medical writing results 
The majority of the efforts on medical writing were focused on 2 publications: a paper on 
bipolar disorder for a pharmaceutical industry client and a paper on smoking cessation for 
a private client. The paper on smoking cessation was performed previously to 2-team 
formation (i.e. previously to the recruitment of the medical writer trainee) and thus did not 
follow the workflow of parallel processing. The major challenges in this task were related 
to the late intervention on the statistical analysis and data management by ARC 
Publishing. The writing task was delivered to us with a poor statistical analysis and 
database already performed by the authors. After revision of the statistical methodology 
we observed the need to re-code the database and perform an improved statistical 
analysis. The activities for the smoking cessation paper demonstrated the inefficiency of 
not planning thoroughly the methodology, which to the writer may originate a complex 
puzzle with several missing pieces.  
The paper on bipolar disorder benefited from early intervention. We planned the figures 
and tables and since the source was the report of randomized controlled trials the 
methodologies were consistent, which was translated in a consistent manuscript. The 
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major challenge in this task was to assemble the (negative) results from 3 large trials. 2 of 
the trials were referent to prevention of manic episodes (early bipolar drug therapy), the 
successful patients of those 2 trials merged in a third trial with the aim to prevent the 
recurrence of manic or depressive episodes (late bipolar drug therapy: mania and 
depression are the 2-poles experienced by unstable bipolar disorder patients). This 
complex design and the different patient groups had to be grouped in flowcharts, tables, 
figures and integrated in a final report. Another challenge of this task was related to the 
inconsistency in the clinical study reports (source documents for this task). The clinical 
study reports were prepared by different medical writing companies, and although it 
followed the same regulatory format, the writing styles and the choice of figures/tables 
differed. Furthermore the reports were of negative results, which means that they were not 
useful to approve the tested drug, and naturally the rigor of the report was affected. 
From the remaining medical writing tasks I underline the efforts in the CRF design, 
regulatory translations and oral communications. The CRF design allowed me to develop 
both my data management and design skills. Regulatory translations, although less 
challenging from the writer perspective, allowed me to understand the requirements of 
CNPD to approve a clinical study. The development of the medical writing course was 
perfect to integrate all the knowledge from the internship and from medical writing 
formations. It offered the perspective of the medical writer lecturer that has the task to 
teach a skill for which a vast hands-on experience is needed. 
4.3 Comments on managing results 
I divided the results of the managing activities in ARC Publishing in quality, brand-related 
and supervision categories.  
The development of an internal quality system supported by SOPs was only partially 
achieved during the internship. Although we were able to outline (in detail) the structure of 
the different SOPs, it was only possible to write some of those procedures. The SOP that 
received most of my attention was the SP on statistical analysis. This procedure details 
the basics on classification of study variables and scientific questions, and the analysis 
(including decision trees) needed to answer the questions for the most common 
configurations of study variables. The focus on other ARC Publishing tasks was the main 
reason to not write the full version of the remaining outlined SOPs. 
A brand is more than a registry or a marketing text, it needs a soul—the mission 
statement. One of the key aspects to achieve a commitment and synchronism in all 
collaborators was to write the company mission statement as a group. This text 
summarizes the brand objective and ideals, which are essential to develop the remaining 
website texts, the newsletters and other marketing communications. To protect the brand 
was the next logic step and the culmination of the brand-management process. It allowed 
me to learn the mechanisms of national and international brand protection and registry. 
Great part of managing work is to interact with colleagues, clients and suppliers. One of 
my tasks was to present projects to clients and to develop business networks. In some 
cases, as with the journal, the client (Editor-in-Chief) close relation allowed the 
development of a strong partnership. By suppliers I refer to companies or individuals that 
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provide us a service that allow us to improve our services. In that class I interacted with 
translators, and the companies responsible for providing us marketing and informatics 
services. In interactions with suppliers it is important to watch for our quality standards 
and company ideals while not degrading professional relationships. Colleagues’ 
interactions in start-up companies are likely to be strong. A small company requires 
constant communication, originating high levels of trust and effectiveness. Participating in 
the supervision of a junior writer was a rewarding experience that allowed me to develop 
leadership skills, essential to motivate and train the company staff.   
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5 Conclusion  
“Think global and act local” is probably a good phrase to convey ARC Publishing strategy. 
We act mainly in 2 fronts, medical writing and publishing. We have seen that although 
(globally) the medical writing market is growing by a justified increase in demand, some of 
that demand has an origin in publishing industry. And if some authors point that peer-
review publications (in the current paradigm) are insupportable for states and reviewers, 
one also cannot ignore that each day more and more journals are created. Those new 
journals are important for pharmaceutical industry and scientists, because an increase in 
publisher offer will boost their chances of publications (even with negative results). ARC 
Publishing was born in a local environment, with few scientific vehicles to achieve 
Portuguese key-opinion leaders, and an increasing demand for medical writing services.  
Beyond medical writing tasks, we were able to structure a company with the quality 
standards, workflow and infrastructure needed to guarantee a prosperous future. And 
future is an adequate word for ARC Publishing, since its workflow is not based on face-to-
face but virtual interactions. The virtuality of the company allows scaling up its resources 
without huge investments (e.g. by recruiting freelance writers that would adopt the 
company procedures), and at the same time presents an opportunity for employees to 
work home-based. 
During my internship I improved my medical writing and editorial skills. But my greater 
gains were in terms of interpersonal and management skills. I was not experienced in 
such a level of independent managing work, which allowed me to understand company, 
client and suppliers needs. Indeed motivation and empowerment are easy to find in small 
start-up companies. Large companies often try to artificially grow ownership culture in 
their staff (by providing bonus for productivity and empowerment for local decisions), but 
the ownership in start-ups is authentic and easily achieved for all collaborators. The sense 
that the company is ours generates trust and aligns the staff goals. 
Writing is hard, if in doubt always remember Hemingway’s quote: "There is nothing to 
writing. All you do is sit down at a typewriter and bleed.” It is a demanding activity and the 
work environment must be flexible to the individual. Some writers write best in awkward 
places: I prefer busy trains, airplanes and shopping malls, but you cannot run a company 
from a train, or can you? 
Globally, I am happy with the results achieved during these 9 months. I grew as 
professional and I contributed significantly for ARC Publishing growing as company.  
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7 Appendices 
 
7.1 IJCNMH Instructions for authors 
 
1. Types of papers 
The International Journal of Clinical Neuroscience and Mental Health publishes 
scientific articles in the following categories: 
 Original research articles.  
 Reviews. 
 Drug reviews. 
 Case reports. 
 Case snippets. 
 Viewpoints. 
 Letters to the editor. 
 Editorials and guest editorials. 
 
1.1. Original research articles 
The International Journal of Clinical Neurosciences and Mental Health welcomes 
original clinical research related with psychiatry, mental health, medical psychology, 
neurosurgery and neurology.  
Reports of randomized clinical trials should follow the CONSORT Guidelines and 
reports of observational studies should comply with STROBE Guidelines.  
Body text of an Original Research Article should have no more than 4000 words (word 
count excludes title page, abstract, acknowledgments, references and tables). A 
maximum of 6 illustrations (figures or tables) are allowed. Supplementary online 
material may be submitted at the editor discretion. 
 
1.2. Review articles and Drug Reviews 
Review articles on CNS-related drugs, psychiatry, mental health, medical psychology, 
neurosurgery and neurology topics are welcome. Both invited and unsolicited 
submissions are accepted. 
Manuscripts should be limited to a maximum of 4,500 words, excluding title page, 
abstract, acknowledgments, references and tables.  
 
1.3. Case reports and case snippets 
Case Reports and Case Snippets should have no more than 750 words (word count 
excludes references) and can include one figure or table.  
Only highly meaningful Case Reports are accepted, including major educational 
content or major clinical findings. Case Snippets should describe a diagnosis or 
therapeutic challenge.  
 
1.4. Viewpoints 
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Viewpoints should provide an expert opinion on important topics for medical research 
or practice, with possibility for covering social and policy aspects. This section 
encourages dialogue and debate on relevant issues with expert views based on 
evidence. 
Viewpoints are limited to 750 words (word count excludes references) and can include 
one figure or table. 
 
1.5. Letters to the Editor 
Letters to the Editor should share views on published articles, any findings insufficient 
for a research article or present ideas of any subject in the scope of the journal. 
Letters to the Editor have a maximum of 600 words (including references) and can 
include one figure or table. 
 
1.6. Editorials and Guest Editorials 
Authors are invited by the Editor-in-Chief to comment on specific topics and express 
their opinions. Editorials and Guest Editorials have a maximum of 1,000 words and can 
include one figure or table. 
 
2. Manuscript Submission 
These instructions advise on how the manuscript should be prepared and submitted. 
Manuscripts that do not comply with the guidelines will not be considered for review. 
All manuscripts should be prepared in A4-size or US-letter size, in UK or US English.  
Manuscripts should be submitted in *.doc and *.pdf formats, in the appropriate section 
of the journal website: IJCNMH online submission. 
 
2.1. Cover Letter 
A cover letter should be submitted together with the manuscript, in *.doc or *.pdf 
format, addressed to the Editor-in-Chief.  
A template for the cover letter is available for download. 
The cover letter should contain statements about originality of your publication, Ethics 
Committee approval and informed consent (if applicable), conflicts of interest and why 
in your opinion your manuscript should be published. 
 
2.2. Manuscript Preparation 
The manuscript must be divided in 2 files: the Title page (submitted in *.doc format and 
*.pdf formats) and the Manuscript body (submitted in *.doc and *.pdf formats).  
 
2.2.1. Title page 
This should be submitted as a separate file from your manuscript (to assure anonymity 
in the peer review process) and should include:   
 Article title. 
 Authors’ names, titles (e.g. MD, PhD, MSc, etc.) and institutional affiliations. 
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 Corresponding author: name, mailing address, telephone and fax numbers. 
 Keywords (maximum of 10). 
 A running head (up to 50 characters). 
 Abstract word count (up to 250 words). 
 Body text word count.  
 The number of figures and tables. 
 
2.2.2. Manuscript body 
The Manuscript body must be anonymous, not containing the names or affiliations of 
the authors. Manuscript body must be structured in the following order: title, abstract, 
body text, acknowledgements, references, tables, and figures captions/legends. 
The text must be formatted as follow: 
 Arial fonts, size: 11 points. 
 Single line spacing (see paragraph menu).  
 Aligned to the left (not justified).  
 Showing continuous line numbers on the left border of the page. For MS Word 
you can add line numbers by going to: Page Layout -> Line Numbers -> select 
“Continuous”; for OpenOffice:  Tools -> Line Numbering -> tick “Show 
numbering”. 
 
2.2.3. Title  
A descriptive and scientifically accurate article title should be provided. 
 
2.2.4. Abstract (250 words maximum) 
An abstract should be prepared for Original Research Articles, Review Articles and 
Drug Reviews. 
Should be structured and include: background/objective, material and methods, results, 
and conclusions. These sections should be separated by the respective headings.  
If the publication is associated with a registered clinical trial, the trial registration 
number should be referred at the end of the abstract. 
 
2.2.5. Body text 
Original research articles 
Original research articles should be structured as follows: 
Introduction: Should present the background for the investigation and justify its 
relevancy. Claims should be supported by appropriate references. Introduction should 
end by stating the objectives of the study. 
Methods: Should allow the reproduction of results and therefore must provide enough 
detail. Appropriate subheadings can be included, if needed. 
Results: Should include detailed descriptions of generated data. This section can be 
separated into subsections with concise self-explanatory subheadings. 
Discussion and Conclusions: Should be brief but comprehensive and well argued, 
summarise and discuss the main findings, their clinical relevance, the strengths and 
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limitations of the study, future perspectives with suggestion of experiments to be 
addressed in the future. 
 
Review articles and Drug Reviews 
These types of articles should be organized in sections and subsections. 
 
2.2.6. Acknowledgements 
This section should name everyone who has contributed to the work but does not 
qualify as an author. People mentioned in this section must be informed and only upon 
consent should their names be included along with their contributions. Financial 
support (with grant number, if applicable) should also be stated here. 
Any conflict of interests should be declared. If authors have no declaration it should be 
written: “The authors declare no conflict of interests”. 
 
2.2.7. References 
References citation in the text should be numbered sequentially along the text, within 
brackets.  
The use of a reference management tool (such as Endnote or Reference Manager) is 
recommended. References must be formatted in Vancouver style.  
Only published or accepted for publication material can be referenced. Personal 
communications can be included in the text but not in the references list.  
 
2.2.8. Tables 
Tables should be smaller than a page, without picture elements or text boxes. Tables 
should have a concise but descriptive title and should be numbered in Arabic numerals. 
Table footnotes should explain any abbreviations or symbols that should be indicated 
by superscript lower-case letters on the body table. 
 
2.2.9. Figures 
Figures should have a concise but descriptive title and should be numbered in Arabic 
numerals. If the article is accepted for publication, the authors may be asked to submit 
higher resolution figures. Copyright pictures shall not be published unless you submit a 
written consent from the copyright holder to allow publishing. 
Each figure file shall not be larger than 30MB.  
Figures should be tested and printed on a personal printer prior submission. The 
printed image, resized to the intended dimensions, is almost a replication of how the 
picture will look online. It shall be clearly perceived, non-pixelated nor grainy. Only 
flattened versions of layered images are allowed. Each figure can only have a 2-point 
white space border, thus cropping is strongly advised. For text within figures, Arial fonts 
between 8 to 11 points should be used and must be readable. When symbols are used, 
the font information should be embedded. 
Photographs should be submitted as *.tif or *.eps at high-resolution (300 dpi or more). 
Graphics should be submitted in *.eps format. MS Office graphics are also acceptable. 
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All figures, tables and graphics should have white background and not transparent. 
Lines, rules and strokes should be between 0.5-1.5 points for reproducibility purposes. 
 
2.3. Supporting Information 
 
2.3.1. Code of Experimental Practice and Ethics 
The minimal ethics requirements are those recommended by the Code of Ethics of the 
World Medical Association (Declaration of Helsinki). Authors should provide information 
regarding ethics on research participants, patient informed consent, data privacy as 
well as competing interests. If the authors have submitted a related manuscript 
elsewhere should disclose this information prior submission.  
 
2.3.2. Nomenclature 
All units should be in International System (SI). Drugs should be designated by their 
International Non-Proprietary Name (INN). 
 
2.4. Submission Checklist 
Please ensure you have addressed the following issues prior submission: 
 Details for competing interests. 
 Details for financial disclosure. 
 Details for authors contribution. 
 Participants informed consent statement. 
 Contributor copyright authorization of figures included in the manuscript, not 
produced by the authors and subjected to copyright. 
 Authorship, affiliations and email addresses are correct. 
 Cover letter addressed to the Editor-in-Chief. 
 Identification of potential reviewers and their email addresses (to be introduced 
at the online submission platform). 
 Manuscript, figure and tables comply with the author guidelines, including the 
correct format, SI units and standard nomenclature. 
 Separated files for Title page (*.doc and *.pdf) and Manuscript body (*.doc and 
*.pdf)—4 in total. 
 Manuscript body does not contain the names or affiliations of the authors. 
If you have any questions, please contact ijcnmh@arc-publishing.org 
 
3. Overview of the Editorial Process 
The International Journal of Clinical Neurosciences and Mental Health aims to provide 
an efficient and constructive view of the manuscripts submitted to achieve a high 
quality level of publications. The editorial board is constituted by expert leaders in 
several areas of medicine particularly in Clinical Neuroscience and Mental Health.   
Once submitted, the manuscript is assigned to an editor which evaluates and decides 
whether the manuscript is accepted for peer-review. At this initial phase, the editor 
evaluates if the manuscript fulfils the scope of the journal according to the content and 
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minimum quality standards.  For peer-review, one or two additional expert field editors 
will comment on the manuscript and decide on whether it is accepted for publishing 
with minor corrections or not accepted for publishing. The editor may ask authors to 
resubmit after major revision. Decision is based on technical and scientific merits of the 
work. Reviewers can be asked to be disclosed or stay anonymous. Authors can 
exclude specific editors or reviewers from the process, upon submission, a rational 
should be provided. 
Upon evaluation, an email is sent to the corresponding author with the decision. If 
accepted, the manuscript enters the production process. It takes approximately 6-7 
weeks for the manuscript to be published. 
 
3.1. Appeal Process 
The editors will respond to appeals from authors which manuscripts were rejected. 
Their interests should be sent to the Editor.  
Two directions can be followed:  
 If the Editor does not accept the appeal, further right to appeal is denied. 
 If the Editor accepts the appeal, a further review will be asked. After the new 
review, the editor can reject or accept the appeal. If rejected, nothing else can 
be done, if accepted the author is able to resubmit the manuscript. 
The reasons for not accepting a manuscript for consideration can be: 
 The manuscript does not follow the scope of the journal. 
 The manuscript has potential interest but there are methodological concerns 
after peer-review or editorial examination. 
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7.2 IJCNMH Cover letter template 
 
[Cover Letter template: the contents should be adapted by the author to the context of 
the publication. Declarations about originality and single submission, authorship, 
conflicts of interest and ethics committee approval/informed consent (if applicable) 
should be present.] 
 
Dear Editor-in-Chief 
International Journal of Clinical Neurosciences and Mental Health 
Professor Dr. Rui Coelho 
 
 
Why the manuscript should be published in the IJCNMH:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Originality and single submission: The results presented in this paper have not been 
published previously in whole or in part, and were not submitted or are not under active 
consideration elsewhere prior IJCNMH decision. The manuscript is authentic and does 
not contain plagiarism. 
 
Authorship:  All authors reviewed the manuscript, agreed with its content, and agreed 
to its submission to the IJCNMH. All the authorship criteria stated by the ICMJE 
Guidelines have been met. 
 
Conflicts of interest: Any conflict of interests should be declared. If authors have no 
declaration it should be written: “the authors declare no conflict of interests”. 
 
Ethics committee and informed consent (if applicable):  The current research was 
approved by an independent ethics committee and subjects gave their informed 
consent before they were enrolled in the study. 
 
 
 
 
Name:          Date: 
(dd/mmm/yyyy) 
 
Signature: 
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7.3 IJCNMH License agreement 
 
Copyright and license agreement 
When submitting an article to the International Journal of Clinical Neurosciences and Mental 
Health (ISSN: ISSN 2182-570X), I certify the following clauses: 
 Originality and single submission – The contents presented in the article have not been 
published previously in whole or in part, and were not submitted or are not under active 
consideration elsewhere prior IJCNMH decision. The article is authentic and does not 
contain plagiarism. 
 Authorship – All authors reviewed the article, agreed with its content, and agreed to its 
submission to the IJCNMH. All the authorship criteria stated by the ICMJE Guidelines 
were met. 
 Conflicts of interest – Any conflict of interests were declared. If authors have no 
declaration, it should be written (in the acknowledgements section): “The authors 
declare no conflict of interests”. 
 Ethics committee and informed consent (if applicable) – The current research was 
approved by an independent ethics committee and subjects gave their informed 
consent before they were enrolled in the study. 
 And I agree to the Open Access license agreement of the International Journal of 
Clinical Neurosciences and Mental Health, stated bellow. 
 
Open Access license agreement of the International Journal of Clinical Neurosciences 
and Mental Health 
 
Summary points: 
Provided only for your convenience—it does not substitute the reading of the full version 
(bellow). 
 
Everyone (a third party) is allowed to: 
 Display, copy, and distribute the work; 
 Make derivative works; 
 Make commercial use of the work; 
But, the third party must (unless waived by the original author): 
 Give credit to the original author; 
 Disclose the license terms of this work for any reuse or distribution. 
 
Full open access license agreement of the International Journal of Clinical Neurosciences and 
Mental Health 
Identical to the Creative Commons Attribution License - cc.3.0 
 
License 
 
THE WORK (AS DEFINED BELOW) IS PROVIDED UNDER THE TERMS OF THIS 
INTERNATIONAL JOURNAL OF CLINICAL NEUROSCIENCES AND MENTAL HEALTH 
LICENSE ("LICENSE"). THE WORK IS PROTECTED BY COPYRIGHT AND/OR OTHER 
APPLICABLE LAW. ANY USE OF THE WORK OTHER THAN AS AUTHORIZED UNDER THIS 
LICENSE OR COPYRIGHT LAW IS PROHIBITED. 
BY EXERCISING ANY RIGHTS TO THE WORK PROVIDED HERE, YOU ACCEPT AND 
AGREE TO BE BOUND BY THE TERMS OF THIS LICENSE. TO THE EXTENT THIS 
LICENSE MAY BE CONSIDERED TO BE A CONTRACT, THE LICENSOR GRANTS YOU THE 
RIGHTS CONTAINED HERE IN CONSIDERATION OF YOUR ACCEPTANCE OF SUCH 
TERMS AND CONDITIONS. 
1. Definitions 
a. "Adaptation" means a work based upon the Work, or upon the Work and other pre-
existing works, such as a translation, adaptation, derivative work, arrangement of music 
or other alterations of a literary or artistic work, or phonogram or performance and 
includes cinematographic adaptations or any other form in which the Work may be 
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recast, transformed, or adapted including in any form recognizably derived from the 
original, except that a work that constitutes a Collection will not be considered an 
Adaptation for the purpose of this License. For the avoidance of doubt, where the Work 
is a musical work, performance or phonogram, the synchronization of the Work in 
timed-relation with a moving image ("synching") will be considered an Adaptation for the 
purpose of this License. 
b. "Collection" means a collection of literary or artistic works, such as encyclopedias and 
anthologies, or performances, phonograms or broadcasts, or other works or subject 
matter other than works listed in Section 1(f) below, which, by reason of the selection 
and arrangement of their contents, constitute intellectual creations, in which the Work is 
included in its entirety in unmodified form along with one or more other contributions, 
each constituting separate and independent works in themselves, which together are 
assembled into a collective whole. A work that constitutes a Collection will not be 
considered an Adaptation (as defined above) for the purposes of this License. 
c. "Distribute" means to make available to the public the original and copies of the Work 
or Adaptation, as appropriate, through sale or other transfer of ownership. 
d. "Licensor" means the individual, individuals, entity or entities that offer(s) the Work 
under the terms of this License. 
e. "Original Author" means, in the case of a literary or artistic work, the individual, 
individuals, entity or entities who created the Work or if no individual or entity can be 
identified, the publisher; and in addition (i) in the case of a performance the actors, 
singers, musicians, dancers, and other persons who act, sing, deliver, declaim, play in, 
interpret or otherwise perform literary or artistic works or expressions of folklore; (ii) in 
the case of a phonogram the producer being the person or legal entity who first fixes the 
sounds of a performance or other sounds; and, (iii) in the case of broadcasts, the 
organization that transmits the broadcast. 
f. "Work" means the literary and/or artistic work offered under the terms of this License 
including without limitation any production in the literary, scientific and artistic domain, 
whatever may be the mode or form of its expression including digital form, such as a 
book, pamphlet and other writing; a lecture, address, sermon or other work of the same 
nature; a dramatic or dramatico-musical work; a choreographic work or entertainment in 
dumb show; a musical composition with or without words; a cinematographic work to 
which are assimilated works expressed by a process analogous to cinematography; a 
work of drawing, painting, architecture, sculpture, engraving or lithography; a 
photographic work to which are assimilated works expressed by a process analogous to 
photography; a work of applied art; an illustration, map, plan, sketch or three-
dimensional work relative to geography, topography, architecture or science; a 
performance; a broadcast; a phonogram; a compilation of data to the extent it is 
protected as a copyrightable work; or a work performed by a variety or circus performer 
to the extent it is not otherwise considered a literary or artistic work. 
g. "You" means an individual or entity exercising rights under this License who has not 
previously violated the terms of this License with respect to the Work, or who has 
received express permission from the Licensor to exercise rights under this License 
despite a previous violation. 
h. "Publicly Perform" means to perform public recitations of the Work and to 
communicate to the public those public recitations, by any means or process, including 
by wire or wireless means or public digital performances; to make available to the public 
Works in such a way that members of the public may access these Works from a place 
and at a place individually chosen by them; to perform the Work to the public by any 
means or process and the communication to the public of the performances of the 
Work, including by public digital performance; to broadcast and rebroadcast the Work 
by any means including signs, sounds or images. 
i. "Reproduce" means to make copies of the Work by any means including without 
limitation by sound or visual recordings and the right of fixation and reproducing 
fixations of the Work, including storage of a protected performance or phonogram in 
digital form or other electronic medium. 
2. Fair Dealing Rights. Nothing in this License is intended to reduce, limit, or restrict any uses 
free from copyright or rights arising from limitations or exceptions that are provided for in 
connection with the copyright protection under copyright law or other applicable laws. 
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3. License Grant. Subject to the terms and conditions of this License, Licensor hereby grants 
You a worldwide, royalty-free, non-exclusive, perpetual (for the duration of the applicable 
copyright) license to exercise the rights in the Work as stated below: 
a. to Reproduce the Work, to incorporate the Work into one or more Collections, and to 
Reproduce the Work as incorporated in the Collections; 
b. to create and Reproduce Adaptations provided that any such Adaptation, including any 
translation in any medium, takes reasonable steps to clearly label, demarcate or 
otherwise identify that changes were made to the original Work. For example, a 
translation could be marked "The original work was translated from English to Spanish," 
or a modification could indicate "The original work has been modified."; 
c. to Distribute and Publicly Perform the Work including as incorporated in Collections; 
and, 
d. to Distribute and Publicly Perform Adaptations. 
e. For the avoidance of doubt: 
i. Non-waivable Compulsory License Schemes. In those jurisdictions in which 
the right to collect royalties through any statutory or compulsory licensing 
scheme cannot be waived, the Licensor reserves the exclusive right to collect 
such royalties for any exercise by You of the rights granted under this License; 
ii. Waivable Compulsory License Schemes. In those jurisdictions in which the 
right to collect royalties through any statutory or compulsory licensing scheme 
can be waived, the Licensor waives the exclusive right to collect such royalties 
for any exercise by You of the rights granted under this License; and, 
iii. Voluntary License Schemes. The Licensor waives the right to collect 
royalties, whether individually or, in the event that the Licensor is a member of a 
collecting society that administers voluntary licensing schemes, via that society, 
from any exercise by You of the rights granted under this License. 
The above rights may be exercised in all media and formats whether now known or hereafter 
devised. The above rights include the right to make such modifications as are technically 
necessary to exercise the rights in other media and formats. Subject to Section 8(f), all rights 
not expressly granted by Licensor are hereby reserved. 
4. Restrictions. The license granted in Section 3 above is expressly made subject to and 
limited by the following restrictions: 
a. You may Distribute or Publicly Perform the Work only under the terms of this License. 
You must include a copy of, or the Uniform Resource Identifier (URI) for, this License 
with every copy of the Work You Distribute or Publicly Perform. You may not offer or 
impose any terms on the Work that restrict the terms of this License or the ability of the 
recipient of the Work to exercise the rights granted to that recipient under the terms of 
the License. You may not sublicense the Work. You must keep intact all notices that 
refer to this License and to the disclaimer of warranties with every copy of the Work You 
Distribute or Publicly Perform. When You Distribute or Publicly Perform the Work, You 
may not impose any effective technological measures on the Work that restrict the 
ability of a recipient of the Work from You to exercise the rights granted to that recipient 
under the terms of the License. This Section 4(a) applies to the Work as incorporated in 
a Collection, but this does not require the Collection apart from the Work itself to be 
made subject to the terms of this License. If You create a Collection, upon notice from 
any Licensor You must, to the extent practicable, remove from the Collection any credit 
as required by Section 4(b), as requested. If You create an Adaptation, upon notice 
from any Licensor You must, to the extent practicable, remove from the Adaptation any 
credit as required by Section 4(b), as requested. 
b. If You Distribute, or Publicly Perform the Work or any Adaptations or Collections, You 
must, unless a request has been made pursuant to Section 4(a), keep intact all 
copyright notices for the Work and provide, reasonable to the medium or means You 
are utilizing: (i) the name of the Original Author (or pseudonym, if applicable) if supplied, 
and/or if the Original Author and/or Licensor designate another party or parties (e.g., a 
sponsor institute, publishing entity, journal) for attribution ("Attribution Parties") in 
Licensor's copyright notice, terms of service or by other reasonable means, the name of 
such party or parties; (ii) the title of the Work if supplied; (iii) to the extent reasonably 
practicable, the URI, if any, that Licensor specifies to be associated with the Work, 
unless such URI does not refer to the copyright notice or licensing information for the 
Work; and (iv) , consistent with Section 3(b), in the case of an Adaptation, a credit 
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identifying the use of the Work in the Adaptation (e.g., "French translation of the Work 
by Original Author," or "Screenplay based on original Work by Original Author"). The 
credit required by this Section 4 (b) may be implemented in any reasonable manner; 
provided, however, that in the case of a Adaptation or Collection, at a minimum such 
credit will appear, if a credit for all contributing authors of the Adaptation or Collection 
appears, then as part of these credits and in a manner at least as prominent as the 
credits for the other contributing authors. For the avoidance of doubt, You may only use 
the credit required by this Section for the purpose of attribution in the manner set out 
above and, by exercising Your rights under this License, You may not implicitly or 
explicitly assert or imply any connection with, sponsorship or endorsement by the 
Original Author, Licensor and/or Attribution Parties, as appropriate, of You or Your use 
of the Work, without the separate, express prior written permission of the Original 
Author, Licensor and/or Attribution Parties. 
c. Except as otherwise agreed in writing by the Licensor or as may be otherwise permitted 
by applicable law, if You Reproduce, Distribute or Publicly Perform the Work either by 
itself or as part of any Adaptations or Collections, You must not distort, mutilate, modify 
or take other derogatory action in relation to the Work which would be prejudicial to the 
Original Author's honor or reputation. Licensor agrees that in those jurisdictions (e.g. 
Japan), in which any exercise of the right granted in Section 3(b) of this License (the 
right to make Adaptations) would be deemed to be a distortion, mutilation, modification 
or other derogatory action prejudicial to the Original Author's honor and reputation, the 
Licensor will waive or not assert, as appropriate, this Section, to the fullest extent 
permitted by the applicable national law, to enable You to reasonably exercise Your 
right under Section 3(b) of this License (right to make Adaptations) but not otherwise. 
5. Representations, Warranties and Disclaimer 
UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING, LICENSOR 
OFFERS THE WORK AS-IS AND MAKES NO REPRESENTATIONS OR WARRANTIES OF 
ANY KIND CONCERNING THE WORK, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, 
INCLUDING, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTIBILITY, 
FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF 
LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OF ABSENCE OF 
ERRORS, WHETHER OR NOT DISCOVERABLE. SOME JURISDICTIONS DO NOT ALLOW 
THE EXCLUSION OF IMPLIED WARRANTIES, SO SUCH EXCLUSION MAY NOT APPLY TO 
YOU. 
6. Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, IN 
NO EVENT WILL LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY FOR ANY 
SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES 
ARISING OUT OF THIS LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS 
BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
7. Termination 
a. This License and the rights granted hereunder will terminate automatically upon any 
breach by You of the terms of this License. Individuals or entities who have received 
Adaptations or Collections from You under this License, however, will not have their 
licenses terminated provided such individuals or entities remain in full compliance with 
those licenses. Sections 1, 2, 5, 6, 7, and 8 will survive any termination of this License. 
b. Subject to the above terms and conditions, the license granted here is perpetual (for the 
duration of the applicable copyright in the Work). Notwithstanding the above, Licensor 
reserves the right to release the Work under different license terms or to stop 
distributing the Work at any time; provided, however that any such election will not 
serve to withdraw this License (or any other license that has been, or is required to be, 
granted under the terms of this License), and this License will continue in full force and 
effect unless terminated as stated above. 
8. Miscellaneous 
a. Each time You Distribute or Publicly Perform the Work or a Collection, the Licensor 
offers to the recipient a license to the Work on the same terms and conditions as the 
license granted to You under this License. 
b. Each time You Distribute or Publicly Perform an Adaptation, Licensor offers to the 
recipient a license to the original Work on the same terms and conditions as the license 
granted to You under this License. 
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c. If any provision of this License is invalid or unenforceable under applicable law, it shall 
not affect the validity or enforceability of the remainder of the terms of this License, and 
without further action by the parties to this agreement, such provision shall be reformed 
to the minimum extent necessary to make such provision valid and enforceable. 
d. No term or provision of this License shall be deemed waived and no breach consented 
to unless such waiver or consent shall be in writing and signed by the party to be 
charged with such waiver or consent. 
e. This License constitutes the entire agreement between the parties with respect to the 
Work licensed here. There are no understandings, agreements or representations with 
respect to the Work not specified here. Licensor shall not be bound by any additional 
provisions that may appear in any communication from You. This License may not be 
modified without the mutual written agreement of the Licensor and You. 
f. The rights granted under, and the subject matter referenced, in this License were 
drafted utilizing the terminology of the Berne Convention for the Protection of Literary 
and Artistic Works (as amended on September 28, 1979), the Rome Convention of 
1961, the WIPO Copyright Treaty of 1996, the WIPO Performances and Phonograms 
Treaty of 1996 and the Universal Copyright Convention (as revised on July 24, 1971). 
These rights and subject matter take effect in the relevant jurisdiction in which the 
License terms are sought to be enforced according to the corresponding provisions of 
the implementation of those treaty provisions in the applicable national law. If the 
standard suite of rights granted under applicable copyright law includes additional rights 
not granted under this License, such additional rights are deemed to be included in the 
License; this License is not intended to restrict the license of any rights under applicable 
law. 
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– MD. 
Affiliations Current: 
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Past: 
– Psychiatric hospitals and Director of a mental health centre in 
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Degrees – Postdoctoral programs, Institute of Psychiatry in London, Columbia 
University. and Mount Sinai School of Medicine (Cultural Psychiatry) 
in New York. 
– PhD, Biological Sciences, Institute of Psychiatry in London. 
– Speciality in Psychiatry, Institute of Psychiatry in London. 
– MD, Federal University of Rio Grande do Sul. 
Affiliations Current: 
– Consultant Psychiatrist at Blacktown Hospital.  
– Conjoint Associate Professor in the School of Medicine of the 
University of Western Sydney, Australia.  
Areas of Interest – Behavioural Pharmacology. 
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– MD. 
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– Professor of Psychiatry, Faculty of Medicine, University of Lisbon. 
– Head of Psychiatric Department – Hospital Santa Maria – University 
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Department of Clinical Physiopathology, Viale Pieraccini. 
Areas of Interest – Sexology. 
– Andrology. 
– Endocrinology. 
Mark Edwards 
Degrees – PhD Doctor of Philosophy London.  
– MBBS Bachelor of Medicine/Bachelor of Surgery London.  
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– Tremor and dystonia. 
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Degrees – PhD, University of Coimbra, Portugal and Max-Planck Institute for 
Brain Research, Germany.  
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– Assistant Professor of Biophysics, Faculty of Medicine, University of 
Coimbra, Portugal.  
Past: 
– Assistant Professor at the University of Maastricht, the Netherlands. 
– Postdoctoral fellow at Max-Planck Institute for Brain Research, 
Department of  Neurophysiology, Frankfurt, Germany. 
Areas of Interest – Visual Neuroscience. 
– Human Psychophysics.  
– Functional Brain Imaging in Humans and Animals.  
– Human and Animal Neurophysiology.  
Myron Belfer 
Degrees – M.P.A., John F. Kennedy School of Government, Harvard University.  
– A.M. (Hon), Harvard University.  
– MD, Albert Einstein College of Medicine.  
– B.A. (Psychology), U of Rochester.  
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Affiliations Current: 
– Professor of Psychiatry in the Department of Social Medicine, Social 
Medicine, Boston, MA. 
Past: 
– Senior Advisor/Consultant, World Health Organization, Geneva, 
Switzerland. 
Areas of Interest – Stress and somatic illness. 
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– Body image development in children with craniofacial abnormalities. 
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College London. 
– Research Associate of the team EA3248 Psychobiology of Emotions 
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